- Home
- Software Solutions
- Resources
- Corporate
Genentech, Inc.
Genentech, Inc. Clinical Studies by Phase of Development
Active Clinical Trials 
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Active | Non-Small-Cell Lung Carcinoma | >OSI-774 (Tarceva) | Phase_II | Study of OSI-774 (Tarceva... | NCT00137800 |
| Active | Pancreatic Cancer | >Gemcitabine >Tarceva | Phase_II | A Phase II Study of Gemci... | NCT00336700 |
| Active | Diabetic Retinopathy Diabetic Macular Edema | >Triamcinolone Acetonide + laser >Ranibizumab + laser >Sham injection + laser >Ranibizumab + deferred laser | Phase_III | Laser-Ranibizumab-Triamci... | NCT00444600 |
| Active | Carcinoma, Non-Small-Cell Lung | >bevacizumab and erlotinib | Phase_II | Study of Bevacizumab and ... | NCT00553800 |
| Active | Ischemic Stroke | >IV tpa (Alteplase) vs IA tpa (Alteplase) | IV vs. IA tPA (Activase) ... | NCT00624000 | |
| Active | Autoimmune Diseases | >Efalizumab | Phase_I Phase_II | Pilot Trial to Assess Eff... | NCT00777400 |
| Active | Colon Cancer | >FOLFOX and bevacizumab | Neoadjuvant FOLFOX Plus B... | NCT00826800 | |
| Active | Hemangioblastomas Von Hippel Lindau Disease | >Avastin | Phase_0 | A Pilot Study of Bevacizu... | NCT01015300 |
| Active | Advanced Renal Cell Carcinoma | >Erlotinib hydrochloride (Tarceva™) >Sirolimus (Rapamune™) | Phase_II | Erlotinib and Sirolimus f... | NCT00353301 |
| Active | Metastatic Colorectal Cancer | >Erlotinib and capecitabine | Phase_II | Study of the Antitumor Ac... | NCT00459901 |
| Active | Cat Allergy | >Omalizumab >Placebo | Phase_II | The Effects of Omalizumab... | NCT01003301 |
| Active | Breast Cancer | >Herceptin >Taxol >Fluorouracil >Cytoxan >Epirubicin | Phase_III | Evaluation of the Additio... | NCT00038402 |
| Active | Breast Cancer | >Peer counseling | Phase_II | Does a Peer Navigator Imp... | NCT00186602 |
| Active | Breast Cancer | >Bevacizumab/Avastin >Cyclophosphamide >Doxorubicin | Phase_II | Primary Systemic Therapy ... | NCT00203502 |
| Active | Hepatocellular Carcinoma Liver Cancer | >Bevacizumab (Avastin) >Erlotinib | Phase_II | Efficacy and Safety Study... | NCT00242502 |
| Active | Glioblastoma Gliosarcoma Brain Tumor | >Avastin, radiation, temozolomide, and irinotecan | Phase_II | Avastin in Combo w XRT & ... | NCT00597402 |
| Active | Prostate Cancer | >Bevacizumab, Erlotinib, Docetaxel, Prednisone | Phase_I Phase_II | Study of Bevacizumab and ... | NCT00996502 |
| Active | Carcinoma, Non-Small-Cell Lung Non-Small Cell Lung Cancer NSCLC | >Erlotinib (tarceva) >Placebo | Phase_III | Erlotinib or Placebo Foll... | NCT00153803 |
| Active | Carcinoma, Non-Small-Cell Lung | >Gemcitabine, Carboplatin, Bevacizumab | Phase_II | Carboplatin and Gemcitabi... | NCT00400803 |
| Active | Proliferative Diabetic Retinopathy Diabetic Macular Edema | >Ranibizumab >Triamcinolone Acetonide >Sham injection | Phase_III | Laser-Ranibizumab-Triamci... | NCT00445003 |
| Active | Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin | >SGN-40 >placebo >rituximab >etoposide >carboplatin >ifosfamide | Phase_II | A Randomized Phase IIb Pl... | NCT00529503 |
| Active | Squamous Cell Carcinoma | >Tarceva, Torisel | Phase_II | Temsirolimus (Torisel®) ... | NCT01009203 |
| Active | Allergic Asthma | >ANTI-IGE THERAPY (XOLAIR) | Phase_IV | A Description of Inflamma... | NCT00283504 |
| Active | Rheumatoid Arthritis | >folate >methotrexate >methylprednisolone >placebo >rituximab | Phase_III | A Study to Evaluate Ritux... | NCT00299104 |
| Active | Head and Neck Cancer | >Bevacizumab >Erlotinib | Phase_II | Treatment of Head & Neck ... | NCT00392704 |
| Active | Complicated Pleural Effusions and Empyemas | >intrapleural instillation of activase | Phase_IV | EffIcicy and Safety of Ac... | NCT00468104 |
| Active | Lymphoma | >Rituximab >Adriamycin >Bleomycin >Vinblastine >Dacarbazine (DTIC) | Phase_II | Rituximab and ABVD for Ho... | NCT00504504 |
| Active | Chronic Rhinosinusitis | >Xolair | Phase_II | Subcutaneous Omalizumab f... | NCT01066104 |
| Active | Chronic Focal Encephalitis Rasmussen's Encephalitis | >Rituximab | Phase_I | A Pilot Study of the Use ... | NCT00259805 |
| Active | Non-small Cell Lung Cancer | >Bevacizumab (Avastin) >Carboplatin >Docetaxel | Phase_II | Avastin/Docetaxel/Carbopl... | NCT00271505 |
| Active | Head and Neck Cancer. Parotid Gland, Thyroid Gland and Melanoma Cases Stage IV Head and Neck Caner | >Erlotinib and bevacizumab | Phase_I | Phase I of Biologics and ... | NCT00405405 |
| Active | Solid Tumor | >ABT-263 >paclitaxel >Carboplatin | Phase_I | Safety Study of ABT-263 i... | NCT00891605 |
| Active | Breast Cancer | >Bevacizumab (drug), Herceptin (drug) | Phase_I Phase_II | Treatment of HER2-Positiv... | NCT00095706 |
| Active | Hemophilia A | >Rituximab | Phase_II | Rituximab to Treat Severe... | NCT00331006 |
| Active | Colorectal Cancer Non-Small Cell Lung Cancer | Phase_IV | A Study of Avastin in Com... | NCT00388206 | |
| Active | Scleritis Orbital Disease | >Rituximab | Phase_I Phase_II | Rituximab in the Treatmen... | NCT00415506 |
| Active | Colorectal Adenocarcinoma | >bevacizumab + everolimus | Phase_II | Expanded Cohort for MCRC ... | NCT00597506 |
| Active | Pancreatic Cancer | >Avastin and Tarceva | Phase_I Phase_II | Phase I/II Trial of Radia... | NCT00735306 |
| Active | Retinal Vein Occlusion | >Ranibizumab .5mg >Ranibizumab .5mg with laser >Ranibizumab 2.0 mg >Ranibizumab 2.o dose with laser | Phase_I Phase_II | Ranibizumab DosE Comparis... | NCT01003106 |
| Active | Cancer | >Bevacizumab | Phase_II | Safety and Efficacy Study... | NCT00177307 |
| Active | Non Small Cell Lung Cancer Lung Cancer | >pemetrexed, cisplatin and erlotinib before surgery then erlotinib is given to patients after surgery for 2 years | Phase_II | Erlotinib and Chemotherap... | NCT00577707 |
| Active | Carcinoma, Non-Small-Cell Lung | >Erlotinib plus hypofractionated radiotherapy | Phase_II | A Study of Erlotinib Plus... | NCT00983307 |
| Active | Growth Hormone Deficiency | >growth hormone administration for 6 months | Consequence of Lifetime I... | NCT00149708 | |
| Active | Non-Small Cell Lung Cancer | >bevacizumab >placebo >erlotinib HCl | Phase_III | A Study Comparing Bevaciz... | NCT00257608 |
| Active | Rheumatoid Arthritis | >methotrexate >methylprednisolone >rituximab | Phase_II | A Study to Evaluate the E... | NCT00282308 |
| Active | Recurrent Glioblastoma | >enzastaurin >bevacizumab | Phase_II | Trial of Enzastaurin and ... | NCT00586508 |
| Active | Growth Hormone Deficiency Pituitary Tumor | Assessment of Cardiovascu... | NCT00646308 | ||
| Active | Non-small Cell Lung Cancer | >erlotinib HCl >MetMAb >placebo | Phase_II | A Study of MetMAb Adminis... | NCT00854308 |
| Active | Solid Tumor | >ABT-263 >Docetaxel | Phase_I | Safety Profile, MTD, and ... | NCT00888108 |
| Active | Lymphoma Lymphoma, Follicular | >ABT-263 | Phase_I Phase_II | A Study of ABT-263 in Sub... | NCT00406809 |
| Active | Solid Cancers | >GDC-0941 | Phase_I | A Study of GDC-0941 in Pa... | NCT00876109 |
| Active | Sarcoma Leiomyosarcoma Malignant Fibrous Histiocytoma Angiosarcoma | >gemcitabine and docetaxel with bevacizumab >gemcitabine and docetaxel with placebo | Phase_II | Gemcitabine and Docetaxel... | NCT00887809 |
| Active | Head and Neck Cancer | >Docetaxel >OSI-774 >Cisplatin | Phase_II | OSI-774/Cisplatin/Taxoter... | NCT00076310 |
| Active | Polypoidal Choroidal Vasculopathy | >ranibizumab intravitreal injection | Phase_I | Ranibizumab for Polypoida... | NCT00424710 |
| Active | Age-Related Macular Degeneration | >Proton beam irradiation and ranibizumab | Phase_0 | Pilot Study of Lucentis C... | NCT00517010 |
| Active | Cervical Cancer | >Bevacizumab >Carboplatin >Radiation Therapy | Phase_II | Neoadjuvant Bevacizumab a... | NCT00600210 |
| Active | Metastatic Colorectal Cancer | >bevacizumab >chemotherapy >GDC-0449 >placebo | Phase_II | A Study of GDC-0449 (Hedg... | NCT00636610 |
| Active | Melanoma | >Ipilimumab >Bevacizumab | Phase_I | Bevacizumab Plus Ipilimum... | NCT00790010 |
| Active | Rheumatoid Arthritis | >infliximab >methotrexate >methylprednisolone >ocrelizumab >sham | Phase_II | A Study to Evaluate Ocrel... | NCT00808210 |
| Active | Non Small Cell Lung Cancer | >Pemetrexed >Bevacizumab >Carboplatin | Phase_II | Trial of Poor Performance... | NCT00892710 |
| Active | Sinusitis | >Anti-IgE antibody omalizumab or placebo | Phase_IV | Xolair in Patients With C... | NCT00117611 |
| Active | Asthma | >Omalizumab | Phase_II Phase_III | Efficacy of Omalizumab as... | NCT00180011 |
| Active | Colorectal Cancer | >Capecitabine (Xeloda) >Bevacizumab | Phase_II | Bevacizumab Plus Capecita... | NCT00203411 |
| Active | Lymphoma | >Fludarabine >Mitoxantrone >Rituximab >Zevalin >Dexamethasone | Phase_II | Rituximab, Fludarabine, M... | NCT00290511 |
| Active | Metastatic Breast Cancer | >trastuzumab-MCC-DM1 | Phase_II | A Study of of Trastuzumab... | NCT00679211 |
| Active | Geographic Atrophy | >FCFD4514S | Phase_I | A Study of the Safety, To... | NCT00973011 |
| Active | Rheumatoid Arthritis | >folate >methotrexate >methylprednisolone >placebo >rituximab | Phase_II | A Study of the Safety and... | NCT00243412 |
| Active | Cancer | >Erlotinib | Phase_II | A Trial of Erlotinib + Ra... | NCT00369512 |
| Active | Ovarian Cancer | >Doxil >Bevacizumab (Avastin) | Phase_II | Efficacy and Safety and P... | NCT00846612 |
| Active | Non-squamous Non-small Cell Lung Cancer | >ixabepilone >bevacizumab | Phase_II | Trial of Bevacizumab and ... | NCT01057212 |
| Active | Growth Hormone Deficiency Septo-Optic Dysplasia Hypopituitarism | >Nutropin AQ | Phase_IV | Endocrine Dysfunction and... | NCT00140413 |
| Active | Esophageal Cancer Gastric Cancer | >Docetaxel >Bevacizumab | Phase_II | Avastin and Taxotere for ... | NCT00137813 |
| Active | Lymphedema | >Bevacizumab | Phase_I | Safety Study of Bevacizum... | NCT00318513 |
| Active | Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer Papillary Serous Mullerian Cancer | >Avastin >erlotinib >paclitaxel >carboplatin | Phase_II | Avastin and Erlotinib as ... | NCT00520013 |
| Active | Neuroendocrine Carcinoma | >Avastin >RAD001 | Phase_II | Avastin (Bevacizumab) and... | NCT00607113 |
| Active | Chronic Lymphocytic Leukemia | >ABT-263 >FCR >BR | Phase_I | Study of ABT-263 When Adm... | NCT00868413 |
| Active | Breast Cancer | >trastuzumab >erlotinib hydrochloride | Phase_II | Trastuzumab and Erlotinib... | NCT00033514 |
| Active | Endothelial Function Rheumatoid Arthritis Inflammation | >Rituxan | Cardiovascular Risk Marke... | NCT00844714 | |
| Active | Lung Cancer | >Docetaxel >Carboplatin >Radiation therapy >Surgical resection | Phase_II | Phase II Docetaxel / Carb... | NCT00238615 |
| Active | Multiple Sclerosis | >interferon beta-1a >methylprednisolone >ocrelizumab >placebo | Phase_II | A Study of the Efficacy a... | NCT00676715 |
| Active | Metastatic Pancreatic Cancer | >Gemcitabine, nab-Paclitaxel, GDC-0449 | Phase_II | Hedgehog Inhibitors for M... | NCT01088815 |
| Active | Rectal Cancer Cancer of the Rectum Colorectal Cancer | >5-Fluorouracil >Bevacizumab >Radiation Therapy >Oxaliplatin >Leucovorin | Phase_II | 5-Fluorouracil, Bevacizum... | NCT00308516 |
| Active | Stomach Neoplasms Esophageal Neoplasms | >Docetaxel, Cisplatin, Fluorouracil, Bevacizumab, Leucovorin | Phase_II | Study of Docetaxel, Cispl... | NCT00390416 |
| Active | Breast Cancer | >Erlotinib | Phase_II | Erlotinib Plus Chemothera... | NCT00491816 |
| Active | Turner Syndrome Hypogonadism Premature Ovarian Failure | >17 B estradiol orally >17 B estradiol | Phase_IV | Estrogen Dosing in Turner... | NCT00837616 |
| Active | Chronic Renal Insufficiency End-Stage Renal Disease | Phase_IV | A Study in Children With ... | NCT00097617 | |
| Active | Renal Cell Carcinoma Kidney Cancer | >Bevacizumab | Phase_II | Neoadjuvant Clinical Tria... | NCT00113217 |
| Active | Breast Cancer | >Bevacizumab >Doxorubicin >Cyclophosphamide >Capecitabine >Docetaxel | Phase_II | Therapy With Bevacizumab ... | NCT00365417 |
| Active | Esophageal Cancer | >erlotinib >5-fluorouracil >leucovorin >oxaliplatin | Phase_II | Chemotherapy & Erlotinib ... | NCT00539617 |
| Active | HER-2 Positive Metastatic Breast Cancer | >Etoposide >Trastuzumab | Phase_II | Phase 2 Study of Trastuzu... | NCT00810017 |
| Active | Basal Cell Carcinoma | >GDC-0449 | Phase_II | A Study Evaluating the Ef... | NCT00833417 |
| Active | Glioblastoma Multiforme Gliosarcoma | >Avastin in combination with temozolomide and irinotecan | Phase_II | Avastin/Temozolomide/Irin... | NCT00979017 |
| Active | Glioblastoma Multiforme Anaplastic Astrocytoma | >Erlotinib | Phase_I Phase_II | Oral Tarceva Study for Re... | NCT00301418 |
| Active | Cervical Cancer | >Topotecan + Cisplatin + Bevacizumab | Phase_II | Topotecan, Cisplatin and ... | NCT00548418 |
| Active | Uveitic Cystoid Macular Edema | >ranibizumab | Phase_I | Pilot Study of Ranibizuma... | NCT00826618 |
| Active | Healthy | >GDC-0449 >GDC-0449 | Phase_I | A Study of the Hedgehog P... | NCT00991718 |
| Active | Breast Cancer | >erlotinib hydrochloride | Phase_II | Erlotinib in Treating Wom... | NCT00024219 |
| Active | Neoplasm Metastasis Lung Cancer | >Bevacizumab >Pemetrexed | Phase_II | Phase II Trial of Bevaciz... | NCT00227019 |
| Active | Primary Biliary Cirrhosis | >rituximab | Phase_I Phase_II | Initial Study of Rituxima... | NCT00364819 |
| Active | Rheumatoid Arthritis | >methotrexate >ocrelizumab >ocrelizumab >placebo | Phase_III | A Study of Ocrelizumab Co... | NCT00406419 |
| Active | Chronic Lymphocytic Leukemia | >Fludarabine >Cyclophosphamide >Rituximab >Bevacizumab | Phase_II | FCR and Bevacizumab in th... | NCT00448019 |
| Active | Ovarian Cancer Peritoneal Cancer Fallopian Tube Cancer | >Paclitaxel >Carboplatin >Avastin | Intraperitoneal Paclitaxe... | NCT00652119 | |
| Active | Malignant Ascites | >Bevacizumab | Phase_II | A Study of Bevacizumab to... | NCT00908219 |
| Active | Healthy | >MABT5102A >MABT5102A | Phase_I | A Study of the Safety, To... | NCT00997919 |
| Active | Ovarian Neoplasms | >Avastin | Phase_II | Pilot Study of Taxol, Car... | NCT00127920 |
| Active | Chromosome 18 Growth Hormone Deficiency | >Nutropin AQ >Arginine and Clonidine Stimulation Testing >Growth Factors Laboratory Testing >Neuropsychological Testing | Phase_III | Growth Hormone and Chromo... | NCT00134420 |
| Active | Asthma | >prednisone | Cell Biology of Steroid R... | NCT00361920 | |
| Active | Advanced Hepatocellular Carcinoma | >ABT-869 | Phase_II | Phase 2 Study of ABT-869 ... | NCT00517920 |
| Active | Macular Degeneration Choroidal Neovascularization | >ranibizumab | Phase_IV | Evaluation of Dosing Inte... | NCT00533520 |
| Active | Rheumatoid Arthritis | >methotrexate >ocrelizumab >placebo | Phase_III | A Study to Evaluate Ocrel... | NCT00673920 |
| Active | Chronic Lymphocytic Leukemia | >Fludarabine Phosphate >Cyclophosphamide >Rituximab | Phase_II | Fludarabine, Cyclophospha... | NCT00794820 |
| Active | Esophageal Cancer Gastric Cancer Stomach Cancer | >Bevacizumab >Cisplatin >Irinotecan >Docetaxel | Phase_II | Cisplatin, Irinotecan and... | NCT00911820 |
| Active | Neoplastic Meningitis | >Bevacizumab | Phase_I Phase_II | A Pilot Study of Bevacizu... | NCT00924820 |
| Active | Pancreatic Cancer | >Erlotinib >capecitabine >Radiation Therapy >gemcitabine >erlotinib | Phase_II | Tarceva With Chemoradiati... | NCT00962520 |
| Active | Choroidal Melanoma | >ranibizumab | Phase_I | Ranibizumab in Combinatio... | NCT00765921 |
| Active | Liver Cancer | >bevacizumab >clinical observation | Phase_II | Chemoembolization and Bev... | NCT00049322 |
| Active | Hepatocellular Carcinoma | >Bevacizumab >Erlotinib | Phase_II | Bevacizumab and Erlotinib... | NCT00287222 |
| Active | Non-small Cell Lung Cancer | >docetaxel; oxaliplatin; bevacizumab | Phase_II | Docetaxel & Oxaliplatin i... | NCT00356122 |
| Active | Breast Cancer | >Trastuzumab >Bevacizumab >Docetaxel | Phase_II | Trastuzumab (Herceptin), ... | NCT00428922 |
| Active | Brain Cancer Recurrent Malignant Gliomas Primary Brain Tumor | >bevacizumab and radiation (IMRT) | Bevacizumab in the Radiat... | NCT00595322 | |
| Active | Malignant Glioma | >LBH589 >bevacizumab | Phase_I Phase_II | LBH589 and Bevacizumab in... | NCT00859222 |
| Active | Non-Hodgkin's Lymphoma Solid Cancers | >GDC-0941 | Phase_I | A Study of GDC-0941 in Pa... | NCT00876122 |
| Active | Metastatic Malignant Melanoma | >Abraxane and Avastin | Phase_II | Abraxane and Avastin as T... | NCT00462423 |
| Active | Ovarian Cancer Primary Peritoneal Serous Cancer Fallopian Tube Cancer | >bevacizumab (Avastin) | Phase_II | Avastin in Patients With ... | NCT00866723 |
| Active | Prostate Cancer | >Erlotinib >Bevacizumab | Phase_II | Treatment of Prostate Can... | NCT00203424 |
| Active | Non-Small Cell Lung Cancer | >Bevacizumab, Oxaliplatin, Pemetrexed | Phase_II | A Phase II Study of Eloxa... | NCT00251524 |
| Active | Unspecified Adult Solid Tumor, Protocol Specific | >Hedgehog antagonist GDC-0449 >gene expression analysis >protein analysis >reverse transcriptase-polymerase chain reaction >liquid chromatography >mass spectrometry >pharmacological study | Phase_I | GDC-0449 in Treating Pati... | NCT00607724 |
| Active | Breast Cancer | >Faslodex >Herceptin | Phase_II | Fulvestrant and/or Trastu... | NCT00138125 |
| Active | Bullous Pemphigoid | >Rituximab | Phase_I Phase_II | Rituximab in the Treatmen... | NCT00286325 |
| Active | Carcinoma | Phase_IV | A Study to Evaluate Corre... | NCT00477425 | |
| Active | Non-small Cell Lung Cancer | >Bevacizumab >AMG 951 (rhApo2L/TRAIL) >Carboplatin >Paclitaxel | Phase_II | A Study of AMG 951 [rhApo... | NCT00508625 |
| Active | Glioblastoma Gliosarcoma | >Avastin and Bortezomib | Phase_II | Ph II Avastin + Bortezomi... | NCT00611325 |
| Active | Macular Edema Uveitis | >triamcinolone >ranibizumab | Phase_II | Study of Uveitic Macular ... | NCT00846625 |
| Active | Dwarfism, Pituitary Turner Syndrome | Phase_IV | Bone Mineral Density (BMD... | NCT00097526 | |
| Active | Glaucoma, Open-Angle Failing Bleb Following Trabeculectomy | >Ranibizumab (Lucentis) | Phase_I | Treatment of Failing Bleb... | NCT00570726 |
| Active | Non-Hodgkin's Lymphoma Solid Cancers | >GDC-0980 | Phase_I | A Study Evaluating GDC-09... | NCT00854126 |
| Active | Rheumatoid Arthritis | >placebo >rituximab >methotrexate >folate | Phase_III | A Study of Retreatment Wi... | NCT00266227 |
| Active | Age-Related Macular Degeneration | >Ranibizumab | ERG/EOG Study in AMD Pati... | NCT00791427 | |
| Active | Psoriasis | Phase_IV | A Study to Evaluate Psori... | NCT00096928 | |
| Active | Non-Small Cell Lung Cancer | >bevacizumab >erlotinib HCl >placebo | Phase_III | A Study to Evaluate the E... | NCT00130728 |
| Active | Glioblastoma Gliosarcoma | >Temodar, Etoposide & Irinotecan | Phase_II | Ph II Bev + Either Temozo... | NCT00613028 |
| Active | Chronic Lymphocytic Leukemia Lymphomas Leukemias | >ABT-263 >ABT-263 >ABT-263 | Phase_I | Oral Bioavailability and ... | NCT00743028 |
| Active | Hemangiosarcoma | >Paclitaxel in combination with Bevacizumab | Phase_II | Paclitaxel + Bevacizumab ... | NCT01055028 |
| Active | Breast Neoplasms | >Allogeneic GM-CSF-secreting breast cancer vaccine >Trastuzumab >Cyclophosphamide | Phase_II | Trastuzumab, Cyclophospha... | NCT00399529 |
| Active | Asthma | Mechanisms of Acute Asthm... | NCT00603629 | ||
| Active | Basal Cell Nevus Syndrome Gorlin Syndrome | >GDC-0449 | Phase_II | The Purpose of This Study... | NCT00957229 |
| Active | Neuroblastoma Opsoclonus-Myoclonus | >anti-CD20 (Rituximab) | Phase_II | Use of Rituximab in Opsoc... | NCT00202930 |
| Active | Rheumatoid Arthritis | >folate >methotrexate >methylprednisolone >placebo >rituximab | Phase_III | A Study to Evaluate Ritux... | NCT00299130 |
| Active | Breast Cancer | >Gemcitabine >Paclitaxel >Bevacizumab | Phase_II | Phase II Gemzar, Taxol & ... | NCT00403130 |
| Active | Esophageal Neoplasms Stomach Neoplasms Neoplasm Metastasis | >capecitabine (Xeloda), oxaliplatin and bevacizumab (Avastin) | Phase_II | Oxaliplatin, Capecitabine... | NCT00447330 |
| Active | Bullous Pemphigoid | >omalizumab >prednisone | Phase_IV | Efficacy and Safety of Om... | NCT00472030 |
| Active | Diabetes Mellitus Macular Edema | >ranibizumab >ranibizumab >sham | Phase_III | A Study of Ranibizumab In... | NCT00473330 |
| Active | Glioblastoma Gliosarcoma | >Bevacizumab and Etoposide | Phase_II | Ph II Bevacizumab + Etopo... | NCT00612430 |
| Active | Asthma | >omalizumab at a dose of 0.016mg/kg/IU/mL >Placebo | Phase_IV | Efficacy of Omalizumab in... | NCT00670930 |
| Active | Polypoidal Choroidal Vasculopathy (PCV) | >ranibizumab 0.5 or 0.3 mg/0.05 cc | Phase_I Phase_II | Ranibizumab (Lucentis) fo... | NCT00837330 |
| Active | Metastatic Breast Cancer | >GDC-0941 >trastuzumab-MCC-DM1 | Phase_I | A Study of Trastuzumab-MC... | NCT00928330 |
| Active | Ocular Histoplasmosis Syndrome | >ranibizumab >ranibizumab | Phase_I Phase_II | Intravitreal Ranibizumab ... | NCT00955630 |
| Active | Non-Hodgkin's Lymphoma | >bendamustine >RO5072759 | Phase_III | A Study to Investigate th... | NCT01059630 |
| Active | Non-small Cell Lung Cancer | >bevacizumab >carboplatin >paclitaxel >placebo >PRO95780 | Phase_II | A Study of PRO95780 in Pa... | NCT00480831 |
| Active | Loco-regional Esophageal Cancer | >bevacizumab >Paclitaxel >Cisplatin >5-Fluorouracil >Radiation Therapy >Esophagectomy | Phase_II | Phase II Trial for Patien... | NCT00570531 |
| Active | Neuroendocrine Tumors | >everolimus (RAD001) >erlotinib | Phase_II | RAD001 and Erlotinib in P... | NCT00843531 |
| Active | Colorectal Cancer | >bevacizumab, capecitabine, oxaliplatin | Phase_II | Study of Oxaliplatin, Cap... | NCT00159432 |
| Active | Rheumatoid Arthritis | >Rituximab | Phase_II | Impact of Rituximab on MR... | NCT00425932 |
| Active | Head and Neck Cancer | >Erlotinib | Phase_II | UAB 0718 - Phase II Trial... | NCT00570232 |
| Active | Hodgkin Lymphoma | >Rituximab >Adriamycin >Bleomycin >Vinblastine >Dacarbazine | Phase_II | Phase II R-ABVD Versus AB... | NCT00654732 |
| Active | Systemic Lupus Erythematosus | >placebo >rontalizumab | Phase_II | A Study to Evaluate the E... | NCT00962832 |
| Active | Age Related Macular Degeneration Choroidal Neovascular Membrane Subfoveal Neovascular Age-Related Macular Degeneration Macular Degeneration Wet Age-Related Macular Degeneration | >Ranibizumab | Phase_I Phase_II | A Study of Intravitreal I... | NCT01025232 |
| Active | Colorectal Cancer | >bevacizumab >FOLFIRI regimen >fluorouracil >irinotecan hydrochloride >leucovorin calcium | Phase_III | Monoclonal Antibody Thera... | NCT00012233 |
| Active | Esophageal Cancer Stomach Cancer | >Bevacizumab >Docetaxel >Cisplatin >Irinotecan | Phase_II | Docetaxel, Cisplatin, Iri... | NCT00394433 |
| Active | Breast Cancer | >cisplatin >bevacizumab >doxorubicin >cyclophosphamide >paclitaxel | Phase_II | Preoperative Cisplatin an... | NCT00580333 |
| Active | Metastatic Breast Cancer Locally Advanced Breast Cancer | >Gemcitabine >Bevacizumab | Phase_II | Gemcitabine Plus Bevacizu... | NCT00623233 |
| Active | Age-Related Macular Degeneration | >combination ranibizumab + bromfenac >ranibizumab injection alone | Phase_II | Combination Ranibizumab a... | NCT00805233 |
| Active | Breast Cancer | >Bevacizumab >Cyclophosphamide >Methotrexate >Capecitabine >Group D | Phase_II | Bevacizumab With or Witho... | NCT00121134 |
| Active | Urologic Neoplasms | >Trastuzumab (Herceptin), Paclitaxel, Carboplatin, Gemcitabine | Phase_II | Trastuzumab (Herceptin), ... | NCT00151034 |
| Active | Allergic Asthma | >Omalizumab >Placebo for Omalizumab >omalizumab | Phase_IV | Effect of Xolair on Airwa... | NCT00208234 |
| Active | Metastatic Melanoma | >RAD001, Bevacizumab | Phase_II | RAD001 Plus Bevacizumab i... | NCT00591734 |
| Active | Advanced or Metastatic Non-Small Cell Lung Cancer | >ABT-869 >Placebo | Phase_II | Study of Carboplatin/Pacl... | NCT00716534 |
| Active | Solid Cancers | >MNRP1685A | Phase_I | A Study of MNRP1685A in P... | NCT00747734 |
| Active | Intraventricular Hemorrhage | >Cathflo Activase >Normal saline | Phase_III | Clot Lysis: Evaluating Ac... | NCT00784134 |
| Active | Non-small Cell Lung Cancer | >erlotinib | Phase_II | Erlotinib Therapy and Sub... | NCT00997334 |
| Active | Asthma | Phase_IV | A Study of Xolair to Eval... | NCT00252135 | |
| Active | Ocular Cicatricial Pemphigoid | >Rituximab | Phase_I Phase_II | Clinical Trial Evaluating... | NCT00584935 |
| Active | Deep Vein Thrombosis Venous Thrombosis Postphlebitic Syndrome Venous Thromboembolism Post Thrombotic Syndrome | >Recombinant tissue plasminogen activator (rt-PA) | Phase_III | Acute Venous Thrombosis: ... | NCT00790335 |
| Active | Macular Degeneration | >ranibizumab >ranibizumab >ranibizumab >ranibizumab | Phase_III | A Study of Ranibizumab Ad... | NCT00891735 |
| Active | Head and Neck Cancer | >bevacizumab, cisplatin, cetuximab, radiation therapy | Phase_II | Bevacizumab, Cetuximab, a... | NCT00968435 |
| Active | Asthma | >lebrikizumab (MILR1444A) >lebrikizumab (MILR1444A) >lebrikizumab (MILR1444A) >placebo | Phase_II | A Study to Evaluate Lebri... | NCT00971035 |
| Active | Intracranial Meningioma | >Everolimus >Bevacizumab | Phase_II | Trial of the Combination ... | NCT00972335 |
| Active | Rectal Cancer Adenocarcinoma of the Rectum | >5-fluorouracil >bevacizumab >erlotinib >External beam radiation therapy (EBRT) | Phase_I Phase_II | Bevacizumab, Erlotinib an... | NCT00307736 |
| Active | Macular Edema Retinal Vein Occlusion | >ranibizumab >sham | Phase_III | A Study of the Efficacy a... | NCT00485836 |
| Active | Presumed Ocular Histoplasmosis (POHS) | >ranibizumab >verteporfin | Phase_II | Ranibizumab Versus PDT fo... | NCT00546936 |
| Active | Malignant Glioma Glioblastoma Multiforme Gliosarcoma | >Taking EIAEDs (enzyme-inducing anticonvulsant medications) >NOT taking EIAEDs | Phase_II | A Study of Gliadel Follow... | NCT00735436 |
| Active | Metastatic Colorectal Cancer | >bevacizumab >FOLFOX >PRO95780 | Phase_I | A Study of PRO95780 Admin... | NCT00851136 |
| Active | Breast Cancer | >bevacizumab >docetaxel >doxorubicin >cyclophosphamide >cyclophosphamide >pegfilgrastim | Phase_III | A Clinical Trial Comparin... | NCT00887536 |
| Active | Triple Negative Breast Cancer | >Temsirolimus, cisplatin, erlotinib | Phase_I | Study of Temsirolimus, Er... | NCT00998036 |
| Active | Ovarian Cancer Primary PERITONEUM Fallopian Tube Cancer | >Paclitaxel,Cisplatin, Bevacizumab | Phase_II | Intravenous and Intraperi... | NCT00588237 |
| Active | Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin | >SGN-40 >rituximab >gemcitabine | Phase_I | Trial to Define the Safet... | NCT00655837 |
| Active | Rheumatoid Arthritis | >corticosteroids >methotrexate >placebo >rituximab | Phase_II | Study to Assess the Effic... | NCT00074438 |
| Active | Breast Cancer | >bevacizumab combined with dose dense chemotherapy | Phase_II | Dose-Dense Chemotherapy P... | NCT00378638 |
| Active | Breast Cancer Breast Neoplasms | >Bevacizumab >Anastrozole >Fulvestrant | Phase_II | Bevacizumab Given With Ei... | NCT00405938 |
| Active | Advanced Renal Cell Carcinoma | >ABT-869 | Phase_II | Study of ABT-869 in Subje... | NCT00486538 |
| Active | Systemic Lupus Erythematosus | >corticosteroids >immunosuppressive regime >methylprednisolone >ocrelizumab >placebo | Phase_III | A Study to Evaluate Two D... | NCT00539838 |
| Active | Proliferative Diabetic Retinopathy | >ranibizumab >Laser photocoagulation | Phase_I Phase_II | Ranibizumab for Treatment... | NCT00606138 |
| Active | Glaucoma New Onset Glaucoma Neovascular Glaucoma New Onset Neovascular Glaucoma | >Ranibizumab (Lucentis) | Phase_I Phase_II | Lucentis for New Onset Ne... | NCT00727038 |
| Active | Esophageal Cancer Gastric Cancer | >epirubicin, cisplatin, capecitabine, bevacizumab, docetaxel and irinotecan | Phase_II | Pre-operative Chemotherap... | NCT00737438 |
| Active | Growth Disorders | Phase_IV | A Postmarketing Surveilla... | NCT00097539 | |
| Active | Breast Cancer | >Herceptin >Taxol >Adriamycin >Cytoxan | Phase_II | Neoadjuvant Therapy With ... | NCT00136539 |
| Active | Adenocarcinoma Non-small Cell Lung Cancer | >Erlotinib | Phase_II | Erlotinib in Women With P... | NCT00137839 |
| Active | Abdominal Abscess, Pelvic Abscess | >Cathflo Activase | Phase_II | Ateplase for Percutaneous... | NCT00284739 |
| Active | Kidney Cancer | >bevacizumab >RAD001 | Phase_II | Bevacizumab (Avastin) and... | NCT00323739 |
| Active | Retinal Vein Occlusion | >Ranibizumab (Lucentis ) | Phase_I | Intravitreal Ranibizumab ... | NCT00403039 |
| Active | Asthma | >omalizumab | Phase_III | Six Months, Open Label St... | NCT00500539 |
| Active | Glioblastoma Gliosarcoma | >Avastin, & temozolomide | Phase_II | Avastin in Combo w Temozo... | NCT00612339 |
| Active | Ovarian Cancer | >Doxil and Avastin | Phase_II | Pharmacokinetic Study of ... | NCT00945139 |
| Active | Membranous Nephropathy | >Rituximab | Phase_II Phase_III | Rituximab in the Treatmen... | NCT00405340 |
| Active | Carcinoma, Renal Cell | >combination of gemcitabine, capecitabine, and bevacizumab | Phase_II | A Phase II Trial of Gemci... | NCT00523640 |
| Active | Prostate Cancer | Molecular Studies and Cli... | NCT00578240 | ||
| Active | Solid Cancers | >MEGF0444A | Phase_I | A Study of the Safety and... | NCT00909740 |
| Active | Breast Cancer | >Trastuzumab (Herceptin) >Trastuzumab (Herceptin) plus Everolimus | Phase_II | Trastuzumab With or Witho... | NCT00912340 |
| Active | Chronic Lymphocytic Leukemia | >Fludarabine >Cyclophosphamide >Rituximab | Phase_II | Protocol for the Treatmen... | NCT00280241 |
| Active | Breast Cancer | >docetaxel >trastuzumab >trastuzumab-MCC-DM1 | Phase_II | A Study of the Efficacy a... | NCT00679341 |
| Active | Non-Hodgkin's Lymphoma | >R-CHOP, R-CHOEP, R-EPOCH >R-ICE, Cyclophosphamide | Phase_II | R-ICE and High-Dose Cyclo... | NCT00809341 |
| Active | Proliferative Diabetic Retinopathy Induced Rubeosis | >Ranibizumab | Phase_I | Use of Ranibizumab to Tre... | NCT01069341 |
| Active | HER-2 Positive Metastatic Breast Cancer | >Docetaxel >Trastuzumab >Erythromycin Breath Test (ERMBT) | Phase_II | UMCC 9901: Phase II Study... | NCT00146042 |
| Active | Ovarian Cancer | >bevacizumab >carboplatin >gemcitabine >placebo | Phase_III | A Study of Carboplatin an... | NCT00434642 |
| Active | Rectal Cancer | >Bevacizumab >Capecitabine >Erlotinib >Radiation Therapy >Surgery | Phase_I Phase_II | Bevacizumab, Erlotinib, a... | NCT00543842 |
| Active | Focal Segmental Glomerulosclerosis (FSGS) | >rituximab | Phase_II | Rituximab Treatment of Fo... | NCT00550342 |
| Active | Osteosarcoma Malignant Fibrous Histiocytoma (MFH) of Bone | >Bevacizumab >Chemotherapy (Cisplatin, Doxorubicin, Methotrexate, Ifosfamide, Etoposide) | Phase_III | A Study of Bevacizumab in... | NCT00667342 |
| Active | Solid Cancers | >bevacizumab >MNRP1685A >paclitaxel | Phase_I | A Study of MNRP1685A in C... | NCT00954642 |
| Active | Cystic Fibrosis | >Oral Glucose tolerance test >Whole body protein turnover >IV glucose tolerance test >Indirect Calorimetry >Dual Energy X-ray Absorptiometry (DEXA) >Growth Hormone Stimulation Test | Metabolic Abnormalities i... | NCT00287443 | |
| Active | Rheumatoid Arthritis | Phase_IV | A Study of the Safety of ... | NCT00443443 | |
| Active | Solid Tumors | >bevacizumab, everolimus, panitumumab | Phase_I | BEP Study Phase I (Bevaci... | NCT00586443 |
| Active | Glioblastoma Gliosarcoma | >Erlotinib, Sirolimus | Phase_II | Ph II Erlotinib + Sirolim... | NCT00672243 |
| Active | Carcinoma | >Paclitaxel >Carboplatin >Bevacizumab >Erlotinib >Other treatment as determined by physician | Phase_II | Treatment Based on Molecu... | NCT00737243 |
| Active | Allergic Asthma | >lebrikizumab (MILR1444A) >placebo | Phase_II | A Study to Evaluate MILR1... | NCT00781443 |
| Active | Solid Tumors | >CNTO 95 and avastin | Phase_I | Safety/Biomarker Study of... | NCT00888043 |
| Active | Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer | >bevacizumab and topotecan | Phase_II | Phase II Study of Weekly ... | NCT00343044 |
| Active | Age-Related Macular Degeneration | >Lucentis (ranibizumab) | Phase_I | CAPTAIN:Choroidal Neovasc... | NCT00500344 |
| Active | Sickle Cell Anemia Retinopathy | >Ranibizumab | Ranibizumab for Neovascul... | NCT00618644 | |
| Active | Non-small Cell Lung Cancer | >erlotinib >hydroxychloroquine | Phase_I | Hydroxychloroquine With o... | NCT01026844 |
| Active | Growth Disorders | Evaluate the Effect of Gr... | NCT00334945 | ||
| Active | Corneal Neovascularization | >Ranibizumab | Phase_I | Ranibizumab for the Inhib... | NCT00769145 |
| Active | Rheumatoid Arthritis | >placebo >PRO283698 | Phase_I | A Study of the Safety and... | NCT00888745 |
| Active | Prostate Cancer Adenocarcinoma of the Prostate | >Bevacizumab >Docetaxel | Phase_II | Neoadjuvant Bevacizumab P... | NCT00321646 |
| Active | Arthritis, Rheumatoid | >Rituximab >Placebo | Phase_III | Safety and Efficacy of Ri... | NCT00468546 |
| Active | Breast Cancer | >Epirubicin >Cyclophosphamide >Docetaxel >Trastuzumab >Bevacizumab | Phase_II | Therapy With Bevacizumab ... | NCT00464646 |
| Active | Metastatic Colorectal Cancer | >Erlotinib | Phase_II | Erlotinib and Chemotherap... | NCT00642746 |
| Active | Stage IIIB or IV Non-Small Cell Lung Cancer | >bevacizumab >pemetrexed >docetaxel >carboplatin | Phase_II | Phase II Avastin Trial fo... | NCT00766246 |
| Active | Head and Neck Cancer | >Erlotinib >Docetaxel >Radiation Therapy | Phase_I | Erlotinib and Docetaxel W... | NCT00113347 |
| Active | Lupus Nephritis | >corticosteroids >methylprednisolone >mycophenolate mofetil >placebo >rituximab | Phase_III | A Study to Evaluate the E... | NCT00282347 |
| Active | Multiple Myeloma | >SGN-40 >lenalidomide >dexamethasone | Phase_I | Study of SGN-40, Lenalido... | NCT00525447 |
| Active | Pancreatic Neoplasms | >Bevacizumab >Gemcitabine >Radiation Therapy | Phase_II | Preop Chemoradiation Rese... | NCT00336648 |
| Active | Neuromyelitis Optica | >Rituximab | Phase_I | Safety and Tolerability o... | NCT00501748 |
| Active | Adenocarcinoma | >bevacizumab >capecitabine >cisplatin >placebo | Phase_III | A Study of Bevacizumab in... | NCT00548548 |
| Active | Allergic Asthma | Phase_IV | Pharmacosurveillance Data... | NCT00813748 | |
| Active | Myelodysplastic Syndrome | >Erlotinib | Phase_II | Erlotinib Study for Myelo... | NCT00977548 |
| Active | Central Retinal Vein Occlusion | >Ranibizumab (Lucentis) | Phase_I | Lucentis for Macular Edem... | NCT01028248 |
| Active | Asthma | >omalizumab >optimized asthma therapy | Phase_IV | Omalizumab in Adult and A... | NCT00264849 |
| Active | Churg-Strauss Syndrome | >Rituximab | Phase_II Phase_III | Rituxan in Churg Strauss ... | NCT00424749 |
| Active | Non-Hodgkin's Lymphoma | >PRO95780 >rituximab | Phase_II | A Study of PRO95780 in Co... | NCT00517049 |
| Active | Systemic Lupus Erythematosus | >rhuMAb IFNalpha | Phase_I | A Study of rhuMAb IFNalph... | NCT00541749 |
| Active | Non-small Cell Lung Cancer | >Docetaxel, Carboplatin, Bevacizumab, Erlotinib >Docetaxel, Carboplatin | Phase_II | Carboplatin, Docetaxel, B... | NCT00621049 |
| Active | Solid Tumors Small Cell Lung Carcinoma | >ABT-263 >etoposide/cisplatin | Phase_I | A Study Evaluating the Sa... | NCT00878449 |
| Active | Primary Sclerosing Cholangitis Trisomy 7 Cholangiocarcinoma Chemoprevention | >Erlotinib (Tarceva) | Phase_I | Erlotinib for Chemopreven... | NCT00955149 |
| Active | Invasive Breast Cancer | >Doxil, Paclitaxel, Cyclophosphamide, Avastin | Phase_II | Therapy for Locally Advan... | NCT00635050 |
| Active | Non-small Cell Lung Cancer | >Paclitaxel >Gemcitabine >Avastin | Phase_II | Lower Dose Chemotherapy G... | NCT00655850 |
| Active | Retinal Vein Occlusion Posterior Vitreous Detachment | >Ranibizumab | Phase_II | Posterior Vitreous Detach... | NCT00831350 |
| Active | Chronic Lymphocytic Leukemia | >rituximab >Fludarabine >Cyclophosphamide | Phase_III | FCR Versus FC Alone in th... | NCT00090051 |
| Active | Constitutional Growth Delay Nutrition Disorders Growth Disorders | >Pediasure >GH | Phase_II | Nutrients and Hormones: E... | NCT00139451 |
| Active | Rheumatoid Arthritis | >rituximab | Phase_III | A Study of the Safety of ... | NCT00443651 |
| Active | Breast Cancer Carcinoma of the Breast | >Paclitaxel >Trastuzumab | Phase_II | Adjuvant Paclitaxel and T... | NCT00542451 |
| Active | Lung Cancer Head and Neck Cancer | >LBH589 >erlotinib | Phase_I Phase_II | Phase I/II Study of LBH58... | NCT00738751 |
| Active | Chronic Lymphocytic Leukemia | >ABT-263 >rituximab | Phase_II | A Study of ABT-263 in Com... | NCT01087151 |
| Active | Turner Syndrome | Phase_IV | A Study to Evaluate Subje... | NCT00097552 | |
| Active | Melanoma | >bevacizumab >carboplatin >paclitaxel >placebo | Phase_II | A Study of Bevacizumab Wi... | NCT00434252 |
| Active | Asthma | Markers of Airway Inflamm... | NCT00838552 | ||
| Active | Non-Hodgkin's Lymphoma Solid Cancers | >GDC-0980 | Phase_I | A Study Evaluating GDC-09... | NCT00854152 |
| Active | Breast Cancer | >Bevacizumab >Cyclophosphamide >methotrexate >Diet Intervention >Exercise Intervention | Phase_III | Bevacizumab, Metronomic C... | NCT00925652 |
| Active | Cholangiocarcinoma | >Gemcitabine, Capecitabine and Bevacizumab | Phase_II | A Study of Gemcitabine, C... | NCT01007552 |
| Active | Asthma | >Pulmicort | Phase_IV | Study of the Mechanisms o... | NCT00595153 |
| Active | Pancreatic Cancer | >Bevacizumab >Erlotinib >Capecitabine >Radiation Therapy | Phase_I | Bevacizumab, Erlotinib an... | NCT00614653 |
| Active | Asthma | >omalizumab >placebo | Phase_IV | A Study to Evaluate the E... | NCT00096954 |
| Active | Pancreatic Cancer | >Tarceva | Phase_I | Pilot Study Using Neoadj ... | NCT00243854 |
| Active | Colorectal Neoplasms Anal, Colon, and Rectal Cancers | >Bevacizumab (Avastin) | Avastin/[18-F]-5-fluorour... | NCT00661154 | |
| Active | Cystic Fibrosis | >Nutropin AQ | Phase_II Phase_III | Growth Hormone Treatment ... | NCT00256555 |
| Active | Macular Edema Retinal Vein Occlusion | >Intravitreal injection of ranibizumab .3 dose >Intravitreal injection of Ranibizumab .5 dose | Phase_I Phase_II | Ranibizumab (Lucentis) fo... | NCT00407355 |
| Active | Uveitis Cytoid Macular Edema | >Lucentis (ranibizumab) | Phase_I Phase_II | Lucentis for Inflammatory... | NCT00498355 |
| Active | Bladder Cancer | >Avastin >Cisplatin >Doxorubicin >Methotrexate >Vinblastine Sulfate | Phase_II | Neoadjuvant Chemotherapy ... | NCT00506155 |
| Active | Head and Neck Cancer | >Erlotinib | Phase_II | Maintenance of Tarceva (E... | NCT00750555 |
| Active | Breast Cancer | Phase_IV | A Study of Patients With ... | NCT00105456 | |
| Active | Lymphoma, Non-Hodgkin MALT Lymphoma | >Fludarabine >Rituximab | Phase_II | Fludarabine and Rituximab... | NCT00117156 |
| Active | Head and Neck Cancer Pharynx Cancer | >bevacizumab >erlotinib (Tarceva) >Bevacizumab and erlotinib | Phase_I Phase_II | Angiogenic and EGFR Block... | NCT00140556 |
| Active | Breast Cancer | >Doxorubicin >Cyclophosphamide >Paclitaxel >Bevacizumab | Phase_II | Preoperative Dose-dense D... | NCT00546156 |
| Active | Brain Cancer Malignant Glioma | >radiotherapy (RT) in combination with temozolomide and bevacizumab | Phase_II | Bevacizumab, Temozolomide... | NCT00782756 |
| Active | Metastatic Colorectal Cancer | >APO2L/TRAIL >bevacizumab >FOLFOX regimen | Phase_I | A Study of Apo2L/TRAIL Ad... | NCT00873756 |
| Active | Non-Small Cell Lung Cancer | >bevacizumab >carboplatin >gemcitabine | Phase_II | Study of Carboplatin/Gemc... | NCT00150657 |
| Active | Prostate Cancer | >bevacizumab, bicalutamide and goserelin >intensity modulated radiation therapy (IMRT) | Phase_II | Bevacizumab With Hormonal... | NCT00349557 |
| Active | Pancreatic Cancer Adenocarcinoma of the Pancreas | >Bevacizumab >Erlotinib >Gemcitabine | Phase_II | Gemcitabine, Bevacizumab ... | NCT00366457 |
| Active | Solid Tumor | >ABT-263 >gemcitabine | Phase_I | Safety Study of ABT-263 i... | NCT00887757 |
| Active | Prostate Cancer | >Bevacizumab >Erlotinib >Imatinib | Phase_I Phase_II | Bevacizumab, Erlotinib, a... | NCT00193258 |
| Active | Kidney Failure, Chronic Growth Hormone Deficiency | >Nutropin AQ | Phase_IV | A Study to Optimize Growt... | NCT00212758 |
| Active | Intraventricular Hemorrhage | >tissue plasminogen activator, rt-PA (thrombolytic) (Cathflo) | Phase_II | Phase II Clinical Trial o... | NCT00650858 |
| Active | Asthma | >huMAb OX40L >placebo | Phase_II | A Study of huMAb OX40L in... | NCT00983658 |
| Active | Carcinoma, Non-Small-Cell Lung | >erlotinib and bexarotene | Phase_II | Study of Tarceva and Targ... | NCT00125359 |
| Active | Lymphoma, B-Cell | >bevacizumab [Avastin] >R-CHOP >Placebo | Phase_III | A Study of Avastin (Bevac... | NCT00486759 |
| Active | Non-small Cell Lung Cancer | >Erlotinib | Phase_II | Erlotinib in Patients Wit... | NCT00567359 |
| Active | Non-small Cell Lung Cancer | >carboplatin >Abraxane >Avastin | Phase_II | Carboplatin, Abraxane, an... | NCT00642759 |
| Active | Endometrial Carcinoma | >carboplatin, paclitaxel, and bevacizumab | Phase_II | Trial of Vascular Endothe... | NCT00879359 |
| Active | Ovarian Cancer | >Bevacizumab | Phase_II | Irinotecan and Bevacizuma... | NCT01091259 |
| Active | Locally Recurrent Breast Cancer Metastatic Breast Cancer | >bevacizumab >GDC-0941 >paclitaxel | Phase_I | A Study of PI3-Kinase Inh... | NCT00960960 |
| Active | Solid Cancers | >GDC-0068 | Phase_I | A Study Evaluating the Sa... | NCT01090960 |
| Active | Opsoclonus-Myoclonus Syndrome Opsoclonus Myoclonus Ataxia | >rituximab | Phase_I Phase_II | Effectiveness of Rituxima... | NCT00244361 |
| Active | Asthma | Phase_IV | An Observational Study of... | NCT00373061 | |
| Active | Neoplasms, Germ Cell and Embryonal | >Bevacizumab and Oxaliplatin | Phase_II | Study of Oxaliplatin Plus... | NCT00393861 |
| Active | Lung Cancer | >Pemetrexed >Gemcitabine >Bevacizumab >Carboplatin | Phase_II | First-Line Treatment of A... | NCT00456261 |
| Active | Metastatic Breast Cancer | >carboplatin >bevacizumab | Phase_II | Phase II Study of Carbopl... | NCT00517361 |
| Active | Pulmonary Alveolar Proteinosis Primary Disease | >rituximab | Phase_II | Prospective Trial of Ritu... | NCT00552461 |
| Active | Mesothelioma | >Carboplatin, Bevacizumab and Pemetrexed | Phase_I Phase_II | Carboplatin, Bevacizumab ... | NCT00604461 |
| Active | Cervical Cancer Uterine Cancer | >Bevacizumab >Paclitaxel | Phase_II | Bevacizumab and Paclitaxe... | NCT00626561 |
| Active | Breast Cancer | Phase_IV | An Observational Study of... | NCT00726661 | |
| Active | Ovarian Cancer | >GDC-0449 >placebo | Phase_II | A Study of GDC-0449 (Hedg... | NCT00739661 |
| Active | Glioblastoma Multiforme | >Radiation therapy >Temozolomide >Bevacizumab >Bevacizumab >Everolimus | Phase_II | RT, Temozolomide, and Bev... | NCT00805961 |
| Active | B-Cell Lymphoma Indolent B-cell Lymphoma | >rituximab | Phase_II | High Dose Rituximab for I... | NCT00895661 |
| Active | Lymphocytic Leukemia, Chronic | >RO5072759 >rituximab >chlorambucil | Phase_III | A Study of RO5072759 With... | NCT01010061 |
| Active | Non-small Cell Lung Cancer | >2-deoxy-2-[18F]fluoro-D-glucose (FDG) >3'-deoxy-3'-[18F]fluorothymidine (FLT) >erlotinib HCl | Phase_I Phase_II | A Study of Changes in FDG... | NCT00453362 |
| Active | Growth Hormone Deficiency | >growth hormone (Nutropin) | Effects of Growth Hormone... | NCT00362063 | |
| Active | Atopic Dermatitis Psoriasis Contact Dermatitis | >microarray analyses. | Phase_II Phase_III | Molecular and Cellular Ch... | NCT00371163 |
| Active | Epithelial Ovarian Cancer Primary Peritoneal Carcinoma | >Bevacizumab >Abraxane | Phase_II | Bevacizumab With Abraxane... | NCT00407563 |
| Active | Breast Cancer Pregnancy | Phase_IV | An Observational Study of... | NCT00833963 | |
| Active | Asthma | >lebrikizumab (MILR1444A) >placebo | Phase_II | A Study of Lebrikizumab (... | NCT00930163 |
| Active | Non-Hodgkin's Lymphoma | >APO2L/TRAIL >rituximab | Phase_I Phase_II | A Study of APO2L/TRAIL in... | NCT00400764 |
| Active | Proliferative Diabetic Retinopathy | >Lucentis (ranibizumab) | Phase_III | Evaluation of Ranibizumab... | NCT00516464 |
| Active | Healthy Asthma | >omalizumab | Phase_IV | The Safety and Utility of... | NCT00777764 |
| Active | Solid Cancers | >bevacizumab >MEGF0444A >paclitaxel | Phase_I | A Study of the Safety and... | NCT01075464 |
| Active | Lymphoma, Non Hodgkin | Phase_IV | An Observational Study of... | NCT00097565 | |
| Active | Squamous Cell Carcinoma of the Head and Neck (SCCHN) | >Bevacizumab >erlotinib >Sulindac | Phase_II | Bevacizumab/Tarceva and T... | NCT00392665 |
| Active | Rheumatoid Arthritis Interstitial Pneumonia | >Rituximab | Phase_III | Rituximab in Rheumatoid A... | NCT00578565 |
| Active | Hodgkin Lymphoma | >Avastin | Phase_II | Avastin (Bevacizumab) Plu... | NCT00722865 |
| Active | Metastatic Breast Cancer | >paclitaxel >pertuzumab >trastuzumab-MCC-DM1 | Phase_I | A Study of Trastuzumab-MC... | NCT00951665 |
| Active | Empyema Pleural Effusion | >Alteplase | Alteplase for Treatment o... | NCT00103766 | |
| Active | Metastatic Breast Cancer | >capecitabine >lapatinib >trastuzumab-MCC-DM1 | Phase_III | An Open-Label Study of Tr... | NCT00829166 |
| Active | Lymphoma Chronic Lymphocytic Leukemia Solid Tumors | >ABT-263 >ABT-263 >ABT-263 >ABT-263 | Phase_I | Assess the Oral Bioavaila... | NCT00982566 |
| Active | Metastatic Breast Cancer | >bevacizumab >chemotherapy >placebo | Phase_III | A Study Evaluating the Ef... | NCT00262067 |
| Active | Neuroendocrine Tumors | >pertuzumab >erlotinib | Phase_II | A Phase II Study of Pertu... | NCT00947167 |
| Active | Solid Cancers | >GDC-0152 | Phase_I | A Study of the Safety and... | NCT00977067 |
| Active | Esophageal Cancer | >Erlotinib >Bevacizumab >Paclitaxel >Carboplatin >5-FU >Radiation therapy >Surgery | Phase_II | Chemotherapy, Radiation T... | NCT00393068 |
| Active | Breast Cancer Cancer of the Breast Breast Neoplasm | >Letrozole (Femara) >Letrozole; Avastin | Phase_II | Comparing Letrozole Given... | NCT00530868 |
| Active | Lupus Erythematosus, Systemic | >placebo >prednisone >rituximab | Phase_II Phase_III | A Study to Evaluate the E... | NCT00137969 |
| Active | Lung Cancer | >bevacizumab >gemcitabine >chemotherapy | Phase_II | Phase II Bevacizumab, Gem... | NCT00323869 |
| Active | Metastatic Breast Cancer | >trastuzumab-MCC-DM1 | Phase_II | A Study of Trastuzumab-MC... | NCT00509769 |
| Active | Prostate Cancer | >RAD001, Docetaxel, Bevacizumab | Phase_I Phase_II | A Study to Test the Safet... | NCT00574769 |
| Active | Intracerebral Hemorrhage | >Cathflo Activase (drug) | Phase_II | MIS+rtPA for ICH Evacuati... | NCT00224770 |
| Active | Glioblastoma Gliosarcoma | >Bevacizumab and Erlotinib | Phase_II | Phase (Ph) II Bevacizumab... | NCT00671970 |
| Active | Metastatic Breast Cancer | >pertuzumab >trastuzumab-MCC-DM1 | Phase_II | A Study of Trastuzumab-MC... | NCT00943670 |
| Active | Non-small Cell Lung Cancer | >Erlotinib >Hydroxychloroquine | Phase_II | Erlotinib With or Without... | NCT00977470 |
| Active | Metastatic Breast Cancer | >Bevacizumab | Phase_II | The Study of Avastin® to... | NCT00240071 |
| Active | Aspirin Sensitive Rhinosinusitis/Asthma | >omalizumab | Phase_IV | Therapeutic Utility of Xo... | NCT00555971 |
| Active | Refractory Myasthenia Gravis | >Rituximab (Rituxan) | Phase_I Phase_II | A Pilot Trial of Rituxan ... | NCT00619671 |
| Active | Cystic Fibrosis | Using Rheological Methods... | NCT00758771 | ||
| Active | Hypopituitarism | >Human Growth hormone - nutropin | Effects of Growth Hormone... | NCT01007071 | |
| Active | Peripheral Neuropathy | >Rituxan | Phase_II | A Study of Rituxan in the... | NCT00006072 |
| Active | Colorectal Cancer | >bevacizumab >fluorouracil >irinotecan hydrochloride >leucovorin calcium | Phase_II | Combination Chemotherapy ... | NCT00012272 |
| Active | Carcinoma, Non-Small-Cell Lung | >erlotinib (Tarceva) and bexarotene (Targretin) | Study of Tarceva and Targ... | NCT00125372 | |
| Active | Prostate Cancer | >Erlotinib (Tarceva) | Phase_II | Study of Erlotinib in Pat... | NCT00148772 |
| Active | Breast Cancer | >Bevacizumab >Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) | Phase_II | Neoadjuvant TAC Plus or M... | NCT00203372 |
| Active | Rheumatoid Arthritis | >rituximab >Placebo | Phase_II | Safety and Tolerability o... | NCT00298272 |
| Active | Colorectal Cancer | >APO2L/TRAIL >bevacizumab >cetuximab >FOLFIRI regimen >irinotecan | Phase_I | A Study of Apo2L/TRAIL Ad... | NCT00671372 |
| Active | Non-Hodgkin's Lymphoma | >rituximab | Phase_III | A Study of Rituximab Alte... | NCT00719472 |
| Active | Metastatic Breast Cancer Breast Cancer Progressive Breast Cancer | >carboplatin >bevacizumab >herceptin | Phase_II | Carboplatin and Bevacizum... | NCT01004172 |
| Active | Asthma | >omalizumab | Phase_II | Effect of Anti-IgE in Non... | NCT00162773 |
| Active | Hormone-Sensitive Breast Cancer Breast Cancer | >Letrozole >Bevacizumab | Phase_II | Randomized Phase II Study... | NCT00461773 |
| Active | Gastroesophageal Cancer Gastric Cancer | >FOLFOX >bevacizumab | Phase_II | FOLFOX With Bevacizumab i... | NCT00673673 |
| Active | Breast Cancer | >Bevacizumab, nab-paclitaxel, carboplatin, doxorubicin hydrochloride, cyclophosphamide, PEG-Filgrastim | Phase_II | Preoperative Chemotherapy... | NCT00777673 |
| Active | Retinal Ischemia | >Panretinal Photocoagulation >Panretinal Photocoagulation and intravitreal injection of ranibizumab | Phase_I Phase_II | Ranibizumab Supplementing... | NCT00841373 |
| Active | Metastatic Breast Cancer | >trastuzumab-MCC-DM1 | Phase_I | A Study of Trastuzumab-MC... | NCT00932373 |
| Active | HIV Infections HIV Seronegativity | >rgp120/HIV-1MN >rgp120/HIV-1 SF-2 >Placebo version of rgp120/HIV-1MN >Placebo version of rgp120/HIV-1SF2 | Phase_I | A Phase I Study to Evalua... | NCT00000774 |
| Active | Neuroendocrine Tumors | >Bevacizumab >Temozolomide | Phase_II | Bevacizumab in Combinatio... | NCT00137774 |
| Active | Breast Cancer | >Abraxane >Bevacizumab >Carboplatin | Phase_II | Phase II Study With Abrax... | NCT00479674 |
| Active | Malignant Glioma Glioblastoma Multiforme Gliosarcoma | >Avastin in Combination with Radiation and Temozolomide followed by Avastin, Temozolomide, and Topotecan | Phase_II | Avastin/Radiation (XRT)/T... | NCT01004874 |
| Active | Branch Retinal Vein Occlusion Central Retinal Vein Occlusion Retinal Vein Occlusion Depression | >ranibizumab (Lucentis) | Phase_I | Impact of Lucentis on Psy... | NCT01011374 |
| Active | Lung Cancer | >Irinotecan >Carboplatin >Bevacizumab | Phase_II | Irinotecan, Carboplatin a... | NCT00193375 |
| Active | Renal Cancer Kidney Cancer | >Bevacizumab | Phase_II | High-dose Bevacizumab in ... | NCT00455975 |
| Active | Alzheimer's Disease | >anti-Abeta >placebo | Phase_I | A Study of the Safety, Ph... | NCT00736775 |
| Active | Renal Cell Carcinoma Kidney Cancer | >avastin >temsirolimus | Phase_II | Avastin and Temsirolimus ... | NCT00782275 |
| Active | Psoriasis | >Efalizumab | Phase_III | Study of the Drug Efalizu... | NCT00115076 |
| Active | HIV Infection | >Nutropin >Oral Glucose Tolerance Test >Dual Energy X-ray Absorptiometry (DEXA) >Computed Tomography (CT) Scan | Phase_II Phase_III | The Use of Nutropin Depot... | NCT00286676 |
| Active | Asthma Allergies | Impact of Asthma Treatmen... | NCT00350376 | ||
| Active | Squamous Cell Carcinoma | >Erlotinib | Phase_II | Erlotinib in Women With S... | NCT00476476 |
| Active | Cancer | >Bevacizumab >Cetuximab >Pemetrexed >Radiation therapy | Phase_II | Radiation, Cetuximab and ... | NCT00703976 |
| Active | Thrombotic Thrombocytopenic Purpura | >Rituximab | Phase_I Phase_II | Use of Rituximab Treatmen... | NCT00251277 |
| Active | Arthritis, Rheumatoid | >Rituximab | Phase_III | Safety and Efficacy Study... | NCT00468377 |
| Active | Coats’ Disease Idiopathic Perifoveal Telangiectasia Retinal Angiomatous Proliferation Polypoidal Vasculopathy Pseudoxanthoma Elasticum Pathological Myopia Multi-Focal Choroiditis Rubeosis Iridis | >ranibizumab injection (0.5 mg) | Phase_I Phase_II | Treatment of Exudative an... | NCT00470977 |
| Active | Colorectal Cancer | Phase_IV | A Study of Avastin With C... | NCT00097578 | |
| Active | Head and Neck Cancer | >Erlotinib (Tarceva) >Intra-arterial Cisplatin (PLAT) >Radiation Therapy (RAD) | Phase_II | Study of RADPLAT and Tarc... | NCT00304278 |
| Active | Colorectal Cancer | >5-Fluorouracil >Bevacizumab >Leucovorin >Irinotecan | Phase_II | Study of FOLFIRI Plus Bev... | NCT00354978 |
| Active | Cystic Fibrosis | >dornase alfa >placebo | Phase_IV | A Trial of Pulmozyme With... | NCT00434278 |
| Active | Multiple Myeloma | >bevacizumab | Phase_II | A Phase II Study of Bevac... | NCT00464178 |
| Active | Psoriatic Arthritis | >Rituximab | Phase_I | Rituxan With or Without M... | NCT00509678 |
| Active | Solid Tumors | >Sorafenib | Phase_I | Sorafenib and Bevacizumab... | NCT00572078 |
| Active | Growth Hormone Deficiency | National Cooperative Grow... | NCT00616278 | ||
| Active | Non-Hodgkins Lymphoma | >Cyclophosphamide >Mitoxantrone >Vincristine >Prednisone >Rituximab | Phase_II | Combination Chemotherapy ... | NCT00193479 |
| Active | Acute Respiratory Distress Syndrome | >Tenecteplase | Phase_I | Treatment of Acute Respir... | NCT00431379 |
| Active | Solid Cancers | >GDC-0973/XL518 | Phase_I | Study of GDC-0973/XL518 i... | NCT00467779 |
| Active | Metastatic Breast Cancer | >pertuzumab >trastuzumab-MCC-DM1 | Phase_I Phase_II | A Study of Trastuzumab-MC... | NCT00875979 |
| Active | Macular Degeneration | >Lucentis (ranibizumab) | Phase_II | Lucentis in Advanced Macu... | NCT00896779 |
| Active | Metastatic Breast Cancer | >Letrozole >Trastuzumab | Phase_II | Letrozole and Herceptin i... | NCT00134680 |
| Active | Biliary Tract Cancer Gallbladder Adenocarcinoma | >Capecitabine >Oxaliplatin >Bevacizumab >Radiation therapy | Phase_II | Capecitabine, Oxaliplatin... | NCT00142480 |
| Active | Otitis Media | >dornase alfa (Pulmozyme®) | Phase_IV | Treatment of Clogged Tymp... | NCT00419380 |
| Active | Glaucoma | >Ranibizumab | Ranibizumab in Preventing... | NCT00644280 | |
| Active | Ulcerative Colitis | >placebo >rhuMAb Beta7 | Phase_I | A Study to Assess the Saf... | NCT00694980 |
| Active | Ovarian Cancer Peritoneal Cancer Fallopian Tube Cancer | >Avastin >cyclophosphamide | Sequential Angiogenic Blo... | NCT00856180 | |
| Active | Diabetic Macular Edema | >Ranibizumab >Laser photocoagulation | Phase_II | The READ-2 Study: Ranibiz... | NCT00407381 |
| Active | Cystoid Macular Edema | >Lucentis (ranibizumab) | Phase_II | Lucentis for Cystoid Macu... | NCT00464581 |
| Active | Globlastoma Multiforme | >Bevacizumab and Temozolomide | Phase_II | Bevacizumab and Temozolom... | NCT00590681 |
| Active | Solid Cancers | >GDC-0449 >GDC-0449 >GDC-0449 | Phase_I | A Study of Hedgehog Pathw... | NCT00968981 |
| Active | Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer | >RAD001 >bevacizumab | Phase_II | Study of RAD001 and Bevac... | NCT01031381 |
| Active | Diabetic Retinopathy Diabetic Macular Edema | >Ranibizumab (Lucentis) >Argon Laser | Phase_II | Efficacy Study of Lucenti... | NCT00387582 |
| Active | Kidney Transplantation Chronic Kidney Failure | >efalizumab | Phase_I Phase_II | Early Conversion From Tac... | NCT00472082 |
| Active | Diabetes Mellitus Macular Edema | >ranibizumab >ranibizumab >sham | Phase_III | A Study of Ranibizumab In... | NCT00473382 |
| Active | Glaucoma | >Ranibizumab >Mytomycin C 0.4 mg/ml | Phase_II Phase_III | Lucentis Versus Mitomycin... | NCT00626782 |
| Active | Kidney Neoplasms | >RAD001 (Certican) >bevacizumab | Phase_II | Treatment of Refractory M... | NCT00651482 |
| Active | Breast Cancer | >bevacizumab >vinorelbine >trastuzumab | Phase_II | Bevacizumab in Combinatio... | NCT00670982 |
| Active | Non-Hodgkin's Lymphoma | >Etoposide, carboplatin, ifosfamide >Rituximab, Ifosfamide, Etoposide, Carboplatin >Rituximab, Ifosfamide, Etoposide, Carboplatin, Stem Cell Collection, Mitoxantrone, Cyclophosphamide and etoposide, Carmustine | Phase_II | Therapy for Patients With... | NCT00712582 |
| Active | Peanut Hypersensitivity | >Peanut Oral Immunotherapy >Omalizumab | Phase_I Phase_II | Peanut Oral Immunotherapy... | NCT00932282 |
| Active | Non-small Cell Lung Cancer Solid Cancers | >erlotinib HCl >GDC-0941 | Phase_I | A Study of the Safety and... | NCT00975182 |
| Active | Trabeculectomy Glaucoma | >ranibizumab | Use of Ranibizumab With M... | NCT00661583 | |
| Active | Advanced Non-squamous Non-Small Cell Lung Cancer | >Carboplatin and Pemetrexed with Bevacizumab 7.5 mg/kg >Carboplatin and Pemetrexed with Bevacizumab 15 mg/kg | Dose Escalation of Bevaci... | NCT01063283 | |
| Active | Myositis Dermatomyositis Polymyositis Juvenile Dermatomyositis | >Rituximab >Placebo | Phase_II | Rituximab for the Treatme... | NCT00106184 |
| Active | Lung Cancer | >Erlotinib >Cisplatin >Docetaxel | Neoadjuvant, Tarceva, Sur... | NCT00254384 | |
| Active | Metastatic Pancreatic Carcinoma | >gemcitabine, capecitabine, and erlotinib | Phase_I | A Phase I Trial of Capeci... | NCT00480584 |
| Active | Non-small Cell Lung Cancer Lung Cancer | >Erlotinib >Carboplatin >Paclitaxel | Phase_II | TARCEVA (Erlotinib) in Co... | NCT00563784 |
| Active | Lymphoproliferative Disorders | >ABT-263 >rituximab | Phase_I | Safety Study of ABT-263 i... | NCT00788684 |
| Active | Persistent Allergic Asthma | >Xolair >Placebo | Phase_IV | Evaluate the Effect of Om... | NCT00870584 |
| Active | Non-small Cell Lung Cancer | >bevacizumab >carboplatin >GDC-0941 >paclitaxel | Phase_I | A Study of the Safety and... | NCT00974584 |
| Active | Breast Cancer | >bevacizumab >capecitabine | Phase_III | Chemotherapy With or With... | NCT00012285 |
| Active | Advanced Cancer Metastatic Cancer | >Rapamycin (liquid) >Bevacizumab >Rapamycin (Tablets) | Phase_I | Rapamycin Plus Bevacizuma... | NCT00667485 |
| Active | Proliferative Diabetic Retinopathy Macular Edema | >ranibizumab >Ranibizumab | Phase_II | Intravitreal Ranibizumab ... | NCT00668785 |
| Active | Asthma | >Xolair injections | Phase_IV | Non-Invasive Measures of ... | NCT00784485 |
| Active | Glioblastoma Multiforme Gliosarcoma | >Tarceva >Temodar >Radiation Therapy | Phase_II | Safety and Efficacy Study... | NCT00187486 |
| Active | Carcinoma, Non-Small-Cell Lung | >Erlotinib | Phase_II | Erlotinib Versus Standard... | NCT00391586 |
| Active | Endometrial Cancer | >Carboplatin/Paclitaxel/Bevacizumab | Phase_II | Evaluation of Carboplatin... | NCT00513786 |
| Active | Breast Cancer | >Ixabepilone >Trastuzumab >Carboplatin | Phase_II | Neoadjuvant Ixabepilone/C... | NCT00821886 |
| Active | Newly Diagnosed High-Grade Gliomas Diffuse Intrinsic Pontine Glioma | >Temozolomide >Bevacizumab >Irinotecan | A Study of Bevacizumab Th... | NCT00890786 | |
| Active | Breast Cancer Metastases | Phase_IV | A Study of Patients With ... | NCT00097487 | |
| Active | Hematological Malignancies | >Rituximab | Phase_I Phase_II | Rituximab for Prevention ... | NCT00379587 |
| Active | Pancreatic Cancer | >Capecitabine, Tarceva | Phase_I | Combination Study of Cape... | NCT00565487 |
| Active | Advanced or Metastatic Solid Tumors | >ABT-869 | Phase_I | Pharmacokinetic Study To ... | NCT00733187 |
| Active | Age Related Macular Degeneration | AREDS 2 Ancillary Spectra... | NCT00734487 | ||
| Active | Asthma | Analysis of Blood-Based B... | NCT00917787 | ||
| Active | Breast Cancer | >Rapamycin >Trastuzumab | Phase_II | A Phase II Study of Rapam... | NCT00411788 |
| Active | Rheumatoid Arthritis | >MTRX1011A | Phase_I | A Study of the Safety, Ph... | NCT00718588 |
| Active | Non-small Cell Lung Cancer | >Ixabepilone >Carboplatin >Bevacizumab | Phase_II | Ixabepilone and Carboplat... | NCT00741988 |
| Active | Rheumatoid Arthritis | >methotrexate >ocrelizumab >placebo | Phase_III | A Study of Ocrelizumab in... | NCT00485589 |
| Active | Non Small Cell Lung Cancer | >erlotinib, sunitinib | Phase_I | Erlotinib and Sunitinib i... | NCT00581789 |
| Active | Advanced Colorectal Cancer | >ABT-869 >bevacizumab >oxaliplatin >folinic acid >fluorouracil >ABT-869 | Phase_II | Phase 2 Study of ABT-869 ... | NCT00707889 |
| Active | Solid Cancers | >carboplatin >docetaxel >trastuzumab | Phase_I | A Study to Evaluate Corre... | NCT00927589 |
| Active | Age Related Macular Degeneration | >ranibizumab (Lucentis(R)) | Phase_II | Retinal and Retinal Pigme... | NCT00931489 |
| Active | Multiple Myeloma | >bevacizumab >bortezomib >placebo | Phase_II | A Study of Bevacizumab in... | NCT00473590 |
| Active | Non-small Cell Lung Cancer (NSCLC) | >ABT-869 | Phase_II | Study of ABT-869 in Subje... | NCT00517790 |
| Active | Antiphospholipid Syndrome | >Rituximab | Phase_II | A Pilot Study of Rituxima... | NCT00537290 |
| Active | Metastatic Breast Cancer | >docetaxel >pertuzumab >placebo >trastuzumab | Phase_III | A Study to Evaluate Pertu... | NCT00567190 |
| Active | Chronic Lymphocytic Leukemia | >ABT-263 | Phase_I Phase_II | A Phase 1/2a Study of ABT... | NCT00481091 |
| Active | Glioblastoma Multiforme Brain and Central Nervous System Tumors Recurrent Malignant Glioma Recurrent Glioblastoma Multiforme | >Bevacizumab and Temozolomide | Phase_II | Bevacizumab in Combinatio... | NCT00501891 |
| Active | Brain Tumor Glioblastoma | >Vorinostst/Bevacizumab/Temozolomide | Phase_I Phase_II | Suberoylanilide Hydroxami... | NCT00939991 |
| Active | Lymphoma, Follicular | >Bevacizumab >Rituximab | Phase_II | A Study of Rituximab and ... | NCT00193492 |
| Active | Breast Cancer | >ABI-007 >Bevacizumab >Trastuzumab | Phase_II | Preoperative Bevacizumab ... | NCT00392392 |
| Active | Advanced Ovarian Carcinoma Primary Peritoneal Carcinoma Ovarian Carcinosarcoma | >Avastin | Phase_II | Study of Bevacizumab Foll... | NCT00511992 |
| Active | Endometrial Cancer | >Avastin | Phase_II | Safety Study Of Avastin A... | NCT00545792 |
| Active | Solid Tumors | >bevacizumab, ABT-510 | Phase_I | A Phase I Study of ABT-51... | NCT00586092 |
| Active | Transitional Cell Carcinoma | >Erlotinib Hydrochloride | Phase_II | Neoadjuvant Erlotinib (Ta... | NCT00749892 |
| Active | Solid Cancers | >GDC-0941 >GDC-0973/XL518 | Phase_I | A Study Evaluating the Sa... | NCT00996892 |
| Active | Glioblastoma Multiforme | >Bevacizumab | Phase_0 | Exploratory Study of the ... | NCT01091792 |
| Active | Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer | >Gemcitabine >Oxaliplatin >Bevacizumab | Phase_II | Oxaliplatin, Gemcitabine ... | NCT00418093 |
| Active | Breast Cancer | >Bevacizumab, Abraxane | Phase_II | Bevacizumab and Abraxane ... | NCT00472693 |
| Active | Lymphoma | >Fludarabine >Novantrone >Decadron >Rituximab >Interferon >Doxorubicin >Vincristine >Bleomycin >Cyclophosphamide >Pr | Phase_III | Fludarabine, Mitoxantrone... | NCT00577993 |
| Active | Carcinoma, Hepatocellular Liver Diseases Neoplasms by Histologic Type Digestive System Neoplasms Carcinoma Liver Neoplasms Neoplasms Neoplasms by Site Digestive System Diseases Adenocarcinoma|Neoplasms, Glandular and Epithelial | >ABT-869 >Sorafenib | Phase_III | Efficacy and Tolerability... | NCT01009593 |
| Active | Leukemia | >Cladribine >Rituximab | Phase_II | 2CDA With Rituximab in Ha... | NCT00412594 |
| Active | Age-Related Macular Degeneration Pigment Epithelial Detachment Neovascular Macular Degeneration Wet Macular Degeneration | >ranibizumab | Phase_II Phase_III | Lucentis for Age-Related ... | NCT00590694 |
| Active | Prostate Cancer | >Androgen Deprivation Therapy >bicalutamide >bevacizumab | Phase_II | Androgen Deprivation Ther... | NCT00776594 |
| Active | Stomach Cancer | >bevacizumab >carboplatin >capecitabine | Phase_II | Ph II of Capecitabine, Ca... | NCT00780494 |
| Active | Non-small Cell Lung Cancer | >erlotinib HCl >pertuzumab | Phase_II | A Study of the Combinatio... | NCT00855894 |
| Active | Macular Edema | >ranibizumab | Phase_III | An Extension Study to Eva... | NCT00379795 |
| Active | Conjunctival Neoplasms | >ranibizumab | Phase_I | Effect of Ranibizumab on ... | NCT00456495 |
| Active | Age-Related Maculopathy | >Lucentis | Phase_IV | Study Evaluating Genotype... | NCT00474695 |
| Active | Non-small Cell Lung Cancer | >Pemetrexed and Gemcitabine plus Bevacizumab | Phase_II | Phase II Study Alimta and... | NCT00517595 |
| Active | Acute Myocardial Infarction | >Tenecteplase >Sterile Saline | Phase_II | A Safety/Efficacy Study o... | NCT00604695 |
| Active | Kidney Failure, Chronic Renal Dialysis | >somatropin | Phase_III | Three Times Weekly (TIW) ... | NCT00943995 |
| Active | Angioid Streaks | >ranibizumab | Phase_I Phase_II | Ranibizumab Therapy for C... | NCT01015495 |
| Active | Advanced Solid Tumors | >Bevacizumab, Everolimus and LBH589 | Phase_I | Safety Study of Bevacizum... | NCT01055795 |
| Active | Breast Cancer | >Herceptin | Phase_II | Neoadjuvant Herceptin in ... | NCT00133796 |
| Active | Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer | >Bevacizumab (drug), Gemcitabine (drug) & Carboplatin (drug) | Phase_II | Study of Gemcitabine/Carb... | NCT00267696 |
| Active | Central Retinal Vein Occlusion | >Ranibizumab | Phase_I | Lucentis for Central Reti... | NCT00406796 |
| Active | Rheumatoid Arthritis | >leflunomide >methotrexate >ocrelizumab >ocrelizumab >placebo | Phase_III | A Study of Ocrelizumab Co... | NCT00476996 |
| Active | Metastatic Breast Cancer | >bevacizumab >chemotherapy >placebo | Phase_III | A Study to Evaluate the S... | NCT00281697 |
| Active | Colorectal Cancer | >bevacizumab >cetuximab >FOLFIRI regimen >irinotecan >PRO95780 | Phase_I | A Study of PRO95780 in Co... | NCT00497497 |
| Active | Lupus Nephritis Systemic Lupus Erythematosus | >corticosteroids >cyclophosphamide >mycophenolate mofetil >ocrelizumab >placebo | Phase_III | A Study to Evaluate Ocrel... | NCT00626197 |
| Active | Prostate Cancer | >Docetaxel >Avastin >Lupron or Zoladex >Bicalutamide | Phase_II | Avastin, Docetaxel and An... | NCT00658697 |
| Active | Renal Transplant Rejection | >Rituximab >No Rituximab | The Effect of Rituximab o... | NCT00695097 | |
| Active | Non-small Cell Lung Cancer | >Carboplatin >Paclitaxel >Bevacizumab | Phase_II | Preoperative Chemotherapy... | NCT00960297 |
| Active | Cystic Fibrosis | >Recombinant Human DNase (Pulmozyme) | Phase_II | Effectiveness of Pulmozym... | NCT00179998 |
| Active | Lymphoma | >Rituximab >Cyclophosphamide >Doxorubicin >Vincristine >Dexamethasone >Methotrexate >Cytarabine >Prednisone | Phase_II | Rituximab-HCVAD in Patien... | NCT00290498 |
| Active | Small Cell Lung Carcinoma Small Cell Lung Cancer | >ABT-263 | Phase_I Phase_II | A Phase 1/2a Study of ABT... | NCT00445198 |
| Active | Multiple Myeloma | >bortezomib >SGN-40 | Phase_I | A Study of the Safety and... | NCT00664898 |
| Active | Breast Cancer | >Docetaxel >Trastuzumab >Carboplatin >Bevacizumab >5-Fluorouracil >Epirubicin >Cyclophosphamide | Phase_III | BETH Study: Treatment of ... | NCT00625898 |
| Active | Recurrent Glioblastoma Multiforme Recurrent Gliosarcoma | >temozolomide and bevacizumab | Phase_II | Bi-Weekly Temozolomide Pl... | NCT00883298 |
| Active | Eosinophilic Esophagitis | >Omalizumab | Phase_I | Identifying Responders to... | NCT01040598 |
| Active | Non-Hodgkin's Lymphoma | >rituximab >SGN-40 | Phase_I | A Study of SGN-40 in Comb... | NCT00556699 |
| Active | Glioblastoma Gliosarcoma | >Erlotinib and Dasatinib | Phase_I | Ph I Dasatinib + Erlotini... | NCT00609999 |
| Active | Radiation Retinopathy Choroidal Melanoma | >Ranibizumab | Phase_I | Effect of Intravitreal Ra... | NCT00750399 |
| Active | Breast Cancer | >PRO Onc Assay >Trastuzumab >Pertuzumab | Use of PRO Onc Assay to A... | NCT01048099 | |
| Active | Brain Cancer | >Temozolomide, bevacizumab, lithium, radiation | Phase_II | Temodar (Temozolomide), B... | NCT01105702 |
| Active | Obesity | >recombinant human growth hormone (rhGH) >Placebo | Phase_II | Effect of rhGH on Viscera... | NCT01169103 |
| Active | Persistent Allergic Asthma | >Omalizumab >Placebo | Phase_III | Omalizumab in Patients Wi... | NCT01202903 |
| Active | Gastrointestinal Cancers | >Capecitabine >Oxaliplatin >Bevacizumab | Phase_II | Bevacizumab With Capecita... | NCT01208103 |
| Active | Glioblastoma Multiforme Gliosarcoma Grade IV Malignant Glioma | >Gliadel (camustine), Radiation, Avastin (bevacizumab), Temodar (temozolomide) | Phase_II | Gliadel, XRT, Temodar, Av... | NCT01186406 |
| Active | Pterygium | >Ranibizumab | Phase_I | Efficacy and Safety of Su... | NCT01169909 |
| Active | Breast Cancer Metastatic Breast Cancer | >trastuzumab >vinorelbine | Phase_II | Trastuzumab and Vinorelbi... | NCT01185509 |
| Active | Non-Hodgkin's Lymphoma CNS Lymphoma | >High-dose chemotherapy with autologous stem cell transplant | Phase_II | High Dose Chemotherapy an... | NCT01182415 |
| Active | Basal Cell Carcinoma | >GDC-0449 | Phase_II | A Study Evaluating the Ef... | NCT01201915 |
| Active | Geographic Atrophy | >FCFD4514S >sham | Phase_II | A Study of Safety, Tolera... | NCT01229215 |
| Active | Kidney Transplantation | >Rituxan | Phase_I Phase_II | Rituximab + Immune Globul... | NCT01178216 |
| Active | Wet Macular Degeneration Macular Degeneration Pigment Epithelium of Eye Retinal Detachment | >ranibizumab >ranibizumab | Phase_II | HiPED - High Dose Lucenti... | NCT01189019 |
| Active | Ovarian Neoplasms | >bevacizumab and erlotinib | Phase_II | Bevacizumab and Erlotinib... | NCT00130520 |
| Active | Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus) | >Bexarotene (Targretin®) >Erlotinib (Tarceva™) | Phase_I | Erlotinib (Tarceva) and B... | NCT01116622 |
| Active | Solid Cancers | >MINT1526A | Phase_I | A Study of the Safety and... | NCT01139723 |
| Active | Epithelial Tumors, Malignant | >MEHD7945A | Phase_I | A Study of the Safety and... | NCT01207323 |
| Active | Healthy Volunteer | >GDC-0941 >GDC-0941 >ketoconazole | Phase_I | A Study to Determine the ... | NCT01240226 |
| Active | Retinal Vein Occlusion | >RBZ | Phase_III | Extended Follow-up of Pat... | NCT01198327 |
| Active | Chronic Lymphocytic Leukemia Non-Hodgkin's Lymphoma | >DCDT2980S | Phase_I | A Study of the Safety and... | NCT01209130 |
| Active | Pancreatic Ductal Adenocarcinoma | >GDC-0449 | Phase_II | Hedgehog Inhibition for P... | NCT01096732 |
| Active | Ischemic Stroke | >Alteplase (iv t-PA) | Phase_I | Safety of Intravenous Thr... | NCT01183533 |
| Active | Retinal Diseases Telangiectasis | >ranibizumab 2.0mg | Phase_II | High-Dose Lucentis (Ranib... | NCT01205035 |
| Active | Fallopian Tubes Cancer Ovarian Cancer Peritoneal Cancer | >bevacizumab and the polyvalent vaccine-KLH conjugate + OPT-821 | Polyvalent Vaccine-KLH Co... | NCT01223235 | |
| Active | Healthy Volunteer | >GDC-0449 >moxifloxacin >placebo | Phase_I | A Study to Investigate th... | NCT01173536 |
| Active | Neuroendocrine Carcinoma Neuroendocrine | >Bevacizumab >Pertuzumab >Sandostatin LAR® Depot | Phase_II | Combination of Bevacizuma... | NCT01121939 |
| Active | Fallopian Tube Neoplasms Ovarian Cancer Primary Peritoneal | >Gemcitabine/Bevacizumab | Phase_II | Safety and Efficacy Study... | NCT01131039 |
| Active | Asthma | >MEMP1972A >placebo | Phase_II | A Study of MEMP1972A in t... | NCT01196039 |
| Active | Glioblastoma Multiforme | >Hypofractionated Intensity-Modulated Radiation Therapy | Phase_II | Hypofractionated Intensit... | NCT01209442 |
| Active | Sarcoma Desmoplastic Small Round Cell Tumor (DSRCT) | >irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylator | Irinotecan, Temozolomide ... | NCT01189643 | |
| Active | Solid Cancers | >GDC-0449 >oral contraceptive >rosiglitazone | Phase_I | A Study of Pharmacokineti... | NCT01209143 |
| Active | Pathological Myopia | >ranibizumab >ranibizumab >verteporfin | Phase_III | Efficacy and Safety of Ra... | NCT01217944 |
| Active | Epithelial Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer | >Carboplatin >Paclitaxel >Bevacizumab | Phase_II | First-line Treatment of W... | NCT01097746 |
| Active | Ischemia Retinal Vein Occlusion Pathologic Processes Retinal Diseases Eye Diseases | >ranibizumab | Phase_I | Study of 2.0 mg Ranibizum... | NCT01225146 |
| Active | Rheumatoid Arthritis | >methotrexate >pneumovax >tetanus toxoid adsorbed >tocilizumab [Actemra] | Phase_IV | A Study of the Effects of... | NCT01163747 |
| Active | Giant Cell Glioblastoma Glioblastoma Gliosarcoma | >bevacizumab >temozolomide >laboratory biomarker analysis >immunohistochemistry staining method >microarray analysis >DNA methylation analysis | Phase_II | Bevacizumab and Temozolom... | NCT01149850 |
| Active | Radiation Necrosis | >Bevacizumab (Avastin®) | The Role of Bevacizumab i... | NCT01201850 | |
| Active | Sinusitis Cystic Fibrosis | >Pulmozyme single use ampule >placebo | Phase_III | Pulmozyme in Cystic Fibro... | NCT01155752 |
| Active | Neuroblastoma | >Bevacizumab, Irinotecan and Temozolomide | Phase_II | Bevacizumab, Irinotecan a... | NCT01114555 |
| Active | Age Related Macular Degeneration | >Ranibizumab >Ranibizumab | Phase_I Phase_II | A Pilot Study to evaLuate... | NCT01115556 |
| Active | Pancreatic Cancer | >Pertuzumab >Erlotinib | Phase_II | A Phase II Study of Pertu... | NCT01108458 |
| Active | Lymphoma, Non-Hodgkin | >Fludarabine >Velcade >Rituximab | Phase_II | Fludarabine, Velcade and ... | NCT01186458 |
| Active | Liver Cancer | >Bevacizumab >Erlotinib | Phase_II | Erlotinib Plus Bevacizuma... | NCT01180959 |
| Active | Allergic Rhinitis | >MEMP1972A >placebo | Phase_I | A Study to Investigate th... | NCT01160861 |
| Active | Sarcoma Soft Tissue Sarcoma Locally Advanced Sarcoma Unresectable Sarcoma Metastatic Sarcoma | >Bevacizumab, Gemcitabine, docetaxel and valproic acid | Phase_I Phase_II | Bevacizumab, Chemotherapy... | NCT01106872 |
| Active | Multiple Myeloma | >MFGR1877S | Phase_I | A Study of the Safety and... | NCT01122875 |
| Active | Solid Cancers | >GDC-0917 | Phase_I | A Study Evaluating the Sa... | NCT01226277 |
| Active | Cystic Fibrosis | >The Medication Adherence Dashboard >Comprehensive Adherence Program | I Change Adherence & Rais... | NCT01232478 | |
| Active | Breast Cancer | >trastuzumab-DM1 >pertuzumab >pertuzumab-placebo >trastuzumab [Herceptin] >docetaxel >paclitaxel | Phase_III | A Study of Trastuzumab-DM... | NCT01120184 |
| Active | Breast Cancer | >bevacizumab >MetMAb >paclitaxel >placebo | Phase_II | A Study Evaluating the Sa... | NCT01186991 |
| Active | Rheumatoid Arthritis | >adalimumab >leflunomide >methotrexate >MLTA3698A >placebo | Phase_II | A Study to Evaluate the E... | NCT01225393 |
| Active | Epithelial Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer | >Carboplatin, paclitaxel, and bevacizumab | Phase_II | Neoadjuvant for Ovarian C... | NCT01146795 |
| Active | Esophageal Cancer Gastric Cancer | >bevacizumab >trastuzumab >oxaliplatin >capecitabine | Phase_II | CAPOX, Bevacizumab and Tr... | NCT01191697 |
| Active | Solid Cancers | >GDC-0623 | Phase_I | A Study Evaluating the Sa... | NCT01106599 |
| Active | Macular Edema | >ranibizumab >ranibizumab >ranibizumab | Phase_IV | A Study Evaluating Dosing... | NCT01277302 |
| Active | Atherosclerosis | >MLDL1278A >MLDL1278A >placebo >statin, stable dose | Phase_II | A Study to Evaluate the S... | NCT01258907 |
| Active | Breast Neoplasms HER2 Protein, Human Geriatric Health Services | >Lapatinib >Trastuzumab | Phase_II | Tolerability of the Combi... | NCT01273610 |
| Active | Idiopathic Short Stature | >Anastrozole and Letrozole >Somatropin >Aromatase inhibitor and somatropin | Phase_III | Aromatase Inhibitors, Alo... | NCT01248416 |
| Active | Solid Cancers | >bevacizumab >carboplatin >GDC-0980 >paclitaxel | Phase_I | A Study of the Safety and... | NCT01301716 |
| Active | Polypoidal Choroidal Vasculopathy | >ranibizumab 2.0mg | Phase_I Phase_II | Safety Study of High-Dose... | NCT01248117 |
| Active | Chronic Idiopathic Urticaria | >omalizumab >placebo | Phase_III | A Study of the Efficacy a... | NCT01287117 |
| Active | Breast Cancer | >bevacizumab >GDC-0980 >paclitaxel >trastuzumab | Phase_I | A Study of the Safety and... | NCT01254526 |
| Active | Age-Related Macular Degeneration | Seven Year Update of Macu... | NCT01256827 | ||
| Active | Brain Cancer | >Vorinostat >Bevacizumab >Bevacizumab >Bevacizumab >Vorinostat | Phase_I Phase_II | Bevacizumab Versus Bevaci... | NCT01266031 |
| Active | Chronic Idiopathic Urticaria | >omalizumab >placebo | Phase_III | A Safety Study of Xolair ... | NCT01264939 |
| Active | Breast Cancer | >pertuzumab in combination with trastuzumab and paclitaxel | Phase_II | Paclitaxel, Trastuzumab, ... | NCT01276041 |
| Active | Chronic Lymphocytic Leukemia | >bendamustine >cyclophosphamide >Fludarabine >RO5072759 | Phase_I | A Study of GA101 (RO50727... | NCT01300247 |
| Active | Chronic Lymphocytic Leukemia Non-Hodgkin's Lymphoma | >DCDS4501A | Phase_I | A Study of Escalating Dos... | NCT01290549 |
| Active | Solid Cancers | >GDC-0032 | Phase_I | A Dose Escalation Study E... | NCT01296555 |
| Active | Head and Neck Neoplasms | >bevacizumab | Phase_II | Pilot Study for Locally A... | NCT01262859 |
| Active | Prostate Cancer | >DSTP3086S | Phase_I | A Study of the Safety and... | NCT01283373 |
| Active | Chronic Idiopathic Urticaria | >omalizumab >placebo | Phase_III | A Study to Evaluate the E... | NCT01292473 |
| Active | Age Related Macular Degeneration | >ranibizumab | Phase_III | Serial Retinal Thickness ... | NCT01255774 |
| Active | Choroidal Melanoma | >Ranibizumab 2 mg >0.5 mg Ranibizumab | Phase_II | Ranibizumab as Adjuvant T... | NCT01251978 |
| Active | Lung Cancer | >Carboplatin >Pemetrexed >Bevacizumab >Cetuximab >Cixutumumab | Phase_II | BATTLE-FL: Front-Line Bio... | NCT01263782 |
| Active | Healthy Volunteer | >GDC-0980 >GDC-0980 >GDC-0980 >GDC-0980 >GDC-0980 >GDC-0980 >rabeprazole | Phase_I | A 3-Part Study to Determi... | NCT01287091 |
| Active | Growth Hormone Deficiency Idiopathic Short Stature | Phase_IV | A Study of Growth in Pati... | NCT01243892 | |
| Active | Brain Cancer | >erlotinib >erlotinib | EGFR Inhibition Using Hig... | NCT01257594 | |
| Active | Diabetic Macular Edema | >Ranibizumab | Phase_I Phase_II | Treatment of Residual Dia... | NCT01292798 |
| Active | Endometrial Cancer | >Carboplatin/Paclitaxel >Trastuzumab | Phase_II | Evaluation of Carboplatin... | NCT01367002 |
| Active | Atopic Asthma | >Bone Marrow Aspiration >Tonsil Biopsy | Kinetics of IgE Memory B ... | NCT01420003 | |
| Active | Solid Cancers | >bevacizumab >capecitabine >GDC-0980 >mFOLFOX6 | Phase_I | GDC-0980 in Combination W... | NCT01332604 |
| Active | Lymphocytic Leukemia, Chronic | >RO5072759 >RO5072759 | Phase_II | A Study Comparing RO50727... | NCT01414205 |
| Active | Brain Cancer MALIGNANT GLIOMA Glioblastoma Anaplastic Astrocytoma (AA) Anaplastic Oligodendroglioma (AO) Anaplastic Oligo-astrocytoma (AOA) Anaplastic Mixed Gliomas Malignant Glioma NOS | >Bevacizumab & stereotactic radiotherapy | Phase_I | Hypofractionated Stereota... | NCT01392209 |
| Active | Diabetic Macular Edema | >Ranibizumab >Ranibizumab | Phase_II | Ranibizumab in Residual D... | NCT01472510 |
| Active | Healthy Volunteer | >MCAF5352A >Placebo | Phase_I | Study to Investigate the ... | NCT01480310 |
| Active | Healthy Volunteer | >GDC-0980 >Ketoconazole | Phase_I | Study to Determine the Ef... | NCT01473316 |
| Active | Polymyalgia Rheumatica (PMR) | >Tocilizumab | Phase_II | Study of Tocilizumab to T... | NCT01396317 |
| Active | Ulcerative Colitis | >rhuMAb Beta7 | Phase_II | Study to Evaluate the Lon... | NCT01461317 |
| Active | Healthy Volunteer | >lebrikizumab (MILR1444A) >placebo | Phase_I | A Study of Lebrikizumab i... | NCT01423318 |
| Active | Colorectal Cancer | >onartuzumab [MetMAb] >Placebo >bevacizumab [Avastin] >FOLFOX regimen >leucovorin >5-FU | Phase_II | FOLFOX/Bevacizumab With O... | NCT01418222 |
| Active | Age-Related Macular Degeneration | >ranibizumab | Phase_IV | Study EvAluating Genotype... | NCT01464723 |
| Active | Healthy | >MLDL1278A >MLDL1278A | Phase_I | Bioavailability Study of ... | NCT01486823 |
| Active | Solid Tumour | >MFGR1877S | Phase_I | Trial Evaluating the Safe... | NCT01363024 |
| Active | Colorectal Cancer | >bevacizumab >FOLFIRI regimen >mFOLFOX6 | Phase_II | Study of Bevacizumab/mFOL... | NCT01374425 |
| Active | Non-Small Cell Lung Cancer | >onartuzumab [MetMAb] >erlotinib [Tarceva] >Placebo | Phase_III | A Study of Onartuzumab (M... | NCT01456325 |
| Active | Chronic Lymphocytic Leukemia Non-Hodgkin's Lymphoma | >ABT-199 | Phase_I | A Phase 1 Study Evaluatin... | NCT01328626 |
| Active | Non-Small Cell Lung Cancer | >bevacizumab >carboplatin >MEGF0444A >paclitaxel >placebo | Phase_II | Study Evaluating the Safe... | NCT01366131 |
| Active | Acute Lung Injury Acute Respiratory Distress Syndrome | >IV Ganciclovir and Valganciclovir >Placebo | Phase_II | Study of Ganciclovir/Valg... | NCT01335932 |
| Active | Stroke | >Anti-platelets and statin >alteplase >intra arterial intervention | Phase_II | Wake up Symptomatic Strok... | NCT01455935 |
| Active | Hereditary Hemorrhagic Telangiectasia (HHT) Nosebleeds | >Ranibizumab | Phase_I | Ranibizumab for the Manag... | NCT01406639 |
| Active | Lymphoma, B-Cell | >navitoclax >bendamustine >rituximab | Phase_II | A Study of Navitoclax in ... | NCT01423539 |
| Active | Healthy Volunteer | >[14C]-GDC-0980 | Phase_I | Study to Investigate the ... | NCT01487239 |
| Active | Solid Cancers | >MPDL3280A | Phase_I | Study of the Safety and P... | NCT01375842 |
| Active | Non-Small Cell Lung Cancer | >RO5490258 >bevacizumab [Avastin] >pemetrexed >Placebo >cisplatin/carboplatin >paclitaxel | Phase_II | A Study of Onartuzumab (M... | NCT01496742 |
| Active | Non-Small Cell Lung Cancer | >GDC-0941 >carboplatin >paclitaxel >bevacizumab >Placebo | Phase_II | Study Evaluating the Safe... | NCT01493843 |
| Active | Age-Related Macular Degeneration | >ranibizumab | Phase_II Phase_III | Clinical Assessment Of Ag... | NCT01402544 |
| Active | Paget's Disease of the Vulva | >trastuzumab | Phase_II | Evaluation of Trastuzumab... | NCT01427244 |
| Active | Healthy | >Dasatinib >Dasatinib plus Rabeprazole >Dasatinib plus Rabeprazole AND Betaine Hydrochloride | Effects of Gastric pH on ... | NCT01398046 | |
| Active | Pulmonary Infections | >Dornase alfa >Sham therapy | Phase_IV | Dornase Alfa Therapy for ... | NCT01356147 |
| Active | Non-Small Cell Lung Cancer, Ovarian Cancer | >DNIB0600A | Phase_I | Safety and Pharmacokineti... | NCT01363947 |
| Active | Diabetic Retinopathy Macular Edema | >Ranibizumab >Ranibizumab | Phase_II | Dosing Study of Ranibizum... | NCT01476449 |
| Active | Melanoma | >Ipilimumab (BMS-734016) >Vemurafenib | Phase_I Phase_II | Ph I/II Ipilimumab Vemura... | NCT01400451 |
| Active | Melanoma | >vemurafenib | Phase_II | Vemurafenib (R05185426) i... | NCT01474551 |
| Active | Multiple Myeloma | >DFRF4539A | Phase_I | A Study of DFRF4539A in P... | NCT01432353 |
| Active | Lymphoma, B-Cell | >RO50722759 >cyclophosphamide >doxorubicin >vincristine >prednisone | Phase_II | A Study of RO5072759 (GA1... | NCT01414855 |
| Active | Healthy Volunteer | >RG7667 >Placebo | Phase_I | A Study of RG7667 in Heal... | NCT01496755 |
| Active | Polypoidal Choroidal Vasculopathy | >ranibizumab 0.5 or 2.0 mg/0.05 cc | Phase_I Phase_II | Safety Study of 2.0mg Luc... | NCT01469156 |
| Active | Ovarian Cancer | >DMUC5754A | Phase_I | Safety and Pharmacokineti... | NCT01335958 |
| Active | Prostate Cancer | >GDC-0068 >GDC-0980 >placebo >abiraterone >prednisone | Phase_II | Study of GDC-0068 Or GDC-... | NCT01485861 |
| Active | Ulcerative Colitis | >placebo >rhuMAb Beta7 | Phase_II | Evaluate the Efficacy and... | NCT01336465 |
| Active | Ovarian Cancer | Phase_IV | Patient Reported Symptoms... | NCT01422265 | |
| Active | Alzheimer's Disease | >MABT5102A >MABT5102A >placebo >placebo | Phase_II | A Study to Evaluate the E... | NCT01343966 |
| Active | Breast Cancer | >fulvestrant >GDC-0941 >GDC-0980 >placebo | Phase_II | Study of GDC-0941 or GDC-... | NCT01437566 |
| Active | Non-Hodgkin's Lymphoma Solid Tumour | >GDC-0349 | Phase_I | Evaluating the Safety and... | NCT01356173 |
| Active | Neuroblastoma Sarcoma | >Cyclophosphamide, Topotecan, and Bevacizumab | Phase_II | Cyclophosphamide, Topotec... | NCT01492673 |
| Active | Solid Cancers | >docetaxel >GDC-0068 >mFOLFOX6 | Phase_I | Safety and Pharmacology o... | NCT01362374 |
| Active | Breast Cancer | >pertuzumab >placebo >trastuzumab [Herceptin] >Chemotherapy | Phase_III | A Study of Pertuzumab in ... | NCT01358877 |
| Active | Alzheimer's Disease | >MABT5102A >MABT5102A >placebo >placebo | Phase_II | A Study to Evaluate the I... | NCT01397578 |
| Active | Radiation Retinopathy | >ranibizumab 2.0 mg | Phase_I | High Dose Intravitreal Ra... | NCT01334879 |
| Active | Metastatic Colorectal Cancer | >bevacizumab >MEGF0444A >mFOLFOX6 >placebo | Phase_II | A Study Evaluating the Ef... | NCT01399684 |
| Active | Wet AMD | Genetics Study of Wet Age... | NCT01310686 | ||
| Active | Melanoma Metastatic Melanoma | >Vemurafenib >Bevacizumab | Phase_II | Trial of Vemurafenib With... | NCT01495988 |
| Active | Proliferative Diabetic Retinopathy | >Prompt Panretinal Photocoagulation >0.5-mg Ranibizumab >Deferred panretinal photocoagulation | Phase_III | Prompt Panretinal Photoco... | NCT01489189 |
| Active | Renal Cell Carcinoma | >everolimus >GDC-0980 | Phase_II | Study of GDC-0980 Versus ... | NCT01442090 |
| Active | Branch Retinal Vein Occlusion Central Retinal Vein Occlusion Macular Edema | >ranibizumab 0.5mg >ranibizumab 1.0mg | Phase_I Phase_II | Intravitreal Ranibizumab ... | NCT01471691 |
| Active | Endometrial Carcinoma | >GDC-0980 | Phase_II | A Study of GDC-0980 in th... | NCT01455493 |
| Active | Ovarian Cancer, Pancreatic Cancer | >DMOT4039A | Phase_I | A Study of DMOT4039A in P... | NCT01469793 |
| Active | Solid Tumour | >GDC-0425 >gemcitabine | Phase_I | A Study Evaluating the Sa... | NCT01359696 |
| Active | Primary Open Angle Glaucoma | STudy to Assess Rapid Dis... | NCT01442896 | ||
| Active | Breast Cancer | >trastuzumab emtansine >anti-cancer therapy | Phase_III | A Study of Trastuzumab Em... | NCT01419197 |
Completed Clinical Trials
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Completed | Asthma | >Xolair (omalizumab) | Phase_III | A Continued Access Protoc... | NCT00109200 |
| Completed | Small Cell Lung Cancer | >Paclitaxel >Bevacizumab | Phase_II | A Study of Paclitaxel Plu... | NCT00317200 |
| Completed | Leukemia, Lymphocytic, Chronic | >SGN-40 (anti-huCD40 mAb) | Phase_I Phase_II | A Safety Study in Patient... | NCT00283101 |
| Completed | Lung Cancer | >Erlotinib >Bevacizumab | Phase_II | Erlotinib With Bevacizuma... | NCT00367601 |
| Completed | Allergic Asthma | >omalizumab | Phase_IV | Study to Evaluate the Eff... | NCT00267202 |
| Completed | Immune Thrombocytopenic Purpura | >Rituxan and Cyclophosphamide, Vincristine and Prednisone >Higher Dose of Rituximab | Phase_II Phase_III | Study of Higher Dose of R... | NCT00774202 |
| Completed | Psoriasis | >Raptiva (efalizumab) | Phase_III | A Study to Evaluate the S... | NCT00096603 |
| Completed | Dermatitis, Atopic | >Efalizumab treatment | Phase_II | Efalizumab for Eczema | NCT00146003 |
| Completed | Small Cell Lung Cancer | >bevacizumab >chemotherapy >placebo | Phase_II | A Study of Bevacizumab in... | NCT00403403 |
| Completed | HIV Infections | >CD4 Antigens | Phase_I | A Phase I Study of the Sa... | NCT00002004 |
| Completed | Osteopenia | >Bisphosphonate | Study of Adults With Low ... | NCT00145704 | |
| Withdrawn | Solid Tumors | >ABT-869 >Tarceva | Phase_I | Study of ABT-869 in Combi... | NCT00754104 |
| Completed | HIV Infections | >CD4 Antigens | A Phase I Study of Recomb... | NCT00002005 | |
| Terminated | Catheterization | >alteplase | Phase_I | Safety and Efficacy of Ti... | NCT00265005 |
| Terminated | Allergy | >Xolair (omalizumab) | Phase_II | A Safety and Efficacy Stu... | NCT00086606 |
| Completed | Colorectal Cancer Neoplasm Metastasis | >erlotinib >FOLFOX >bevacizumab | Phase_II | Study of Bevacizumab, Erl... | NCT00116506 |
| Completed | Cystic Fibrosis | Phase_IV | A Study to Determine the ... | NCT00311506 | |
| Completed | Lichen Planus, Oral | >efalizumab | Safety and Effectiveness ... | NCT00133107 | |
| Completed | Macular Degeneration | >Lucentis >Ranibizumab >Ranibizumab (Lucentis) >Ranibizumab (Lucentis) | Phase_I Phase_II | Study To Determine Safety... | NCT00395707 |
| Completed | Asthma | >Omalizumab | Phase_III | Safety and Tolerability o... | NCT00482508 |
| Completed | Pancreatic Cancer | >Bevacizumab >Capecitabine >Radiotherapy | Phase_I | Study of Combined RHUMAB ... | NCT00047710 |
| Terminated | Lupus Erythematosus, Systemic | >methylprednisolone >rituximab | Phase_II Phase_III | A Study for Patients Prev... | NCT00381810 |
| Completed | Cystic Fibrosis | >Human recombinant growth hormone | Phase_III | Growth Hormone Use in Cys... | NCT00005112 |
| Completed | Plaque Psoriasis | >Raptiva (efalizumab) | Phase_I | A Study to Evaluate the E... | NCT00382512 |
| Completed | Asthma | >omalizumab >placebo | Phase_IV | A Study of Omalizumab in ... | NCT00495612 |
| Terminated | Chondrosarcoma | >PRO95780 | Phase_II | A Study of PRO95780 in Pa... | NCT00543712 |
| Metastatic Breast Cancer | >trastuzumab-MCC-DM1 | Phase_II | An Extension Study of T-D... | NCT00781612 | |
| Completed | Dwarfism, Pituitary | Phase_IV | National Cooperative Grow... | NCT00097513 | |
| Completed | Renal Cell Carcinoma Metastases | >Avastin (bevacizumab) >Tarceva (erlotinib HCl) | Phase_II | A Study Evaluating Tarcev... | NCT00081614 |
| Completed | Psoriasis | >efalizumab >placebo | Phase_IV | A Study to Evaluate the S... | NCT00669214 |
| Terminated | Melanoma | >INO-1001 >temozolomide | Phase_I | A Study of Intravenous IN... | NCT00272415 |
| Completed | Kidney Insufficiency | >Rituximab | Phase_I | Rituximab Therapy for Pat... | NCT00476515 |
| Completed | Multiple Myeloma | >SGN-40 (anti-huCD40 mAb) | Phase_I | Study of SGN-40 in Patien... | NCT00079716 |
| Completed | Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin | >SGN-40 | Phase_II | Study of SGN-40 in Patien... | NCT00435916 |
| Terminated | Cystic Fibrosis | >dornase alfa >placebo | Phase_IV | A Study of Pulmozyme® (D... | NCT00680316 |
| Completed | Psoriasis | >Raptiva (efalizumab) | Phase_III | A Study to Evaluate Rapti... | NCT00109317 |
| Completed | Membranous Nephropathy | >Rituximab | Phase_II Phase_III | Rituximab in Membranous N... | NCT00425217 |
| Completed | Breast Cancer | An Observational Study of... | NCT00153218 | ||
| Completed | Dysfunctional Central Venous Access Catheters | >tenecteplase | Phase_III | A Study of Tenecteplase f... | NCT00396318 |
| Completed | Macular Edema Retinal Vein Occlusion | >ranibizumab >ranibizumab >sham | Phase_III | A Study of the Efficacy a... | NCT00486018 |
| Withdrawn | Sarcoidosis | >Rituximab | Phase_II | A Prospective Open-Label ... | NCT00552318 |
| Completed | Ovarian Cancer | >bevacizumab | Phase_II | A Study of Bevacizumab in... | NCT00097019 |
| Completed | HIV Infections | >rgp120/HIV-1IIIB >rgp120/HIV-1MN | Phase_I | A Phase I Study of the Sa... | NCT00001020 |
| Completed | Healthy Female Subjects | >ABT-263 >ABT-263 >ABT-263 | Phase_I | Assess the Oral Bioavaila... | NCT01053520 |
| Completed | HIV Infections | >rgp120/HIV-1IIIB >rgp120/HIV-1MN | Phase_I | A Phase I Multicenter Stu... | NCT00001021 |
| Completed | Pancreatic Cancer Neoplasm Metastasis | >Capecitabine >OSI-774 | Phase_II | Tarceva and Capecitabine ... | NCT00125021 |
| Completed | Neoplasms, Unknown Primary | >Bevacizumab >Erlotinib | Phase_II | Bevacizumab and Erlotinib... | NCT00193622 |
| Completed | Lung Cancer | >Avastin >Tarceva | Phase_I Phase_II | Avastin and Tarceva for L... | NCT00043823 |
| Completed | Age-Related Maculopathy | >rhuFab V2 (ranibizumab) | Phase_I Phase_II | Intravitreal Injections o... | NCT00056823 |
| Completed | Macular Degeneration | >rhuFab V2 (ranibizumab) | Phase_III | A Study of rhuFab V2 (Ran... | NCT00090623 |
| Terminated | Pancreatic Cancer Pancreatic Ductal Adenocarcinoma | >bevacizumab >5-Fluorouracil >Oxaliplatin >gemcitabine >External Beam Radiation Therapy | Phase_I Phase_II | Study of Bevacizumab in C... | NCT00307723 |
| Completed | Non-Small-Cell Lung Carcinoma Neoplasm Recurrence, Local | >Avastin (bevacizumab) >Tarceva (erlotinib HCl) | Phase_II | A Study to Evaluate Bevac... | NCT00095225 |
| Completed | Central Serous Chorioretinopathy | >rhuFab V2 [ranibizumab] ( Lucentis ) | Phase_I | Intravitreal Ranibizumab ... | NCT00403325 |
| Completed | Colorectal Cancer | >Avastin (Bevacizumab) | Phase_II | A Study to Evaluate Avast... | NCT00109226 |
| Completed | Psoriasis | >efalizumab | Phase_IV | A Study to Evaluate the S... | NCT00312026 |
| Terminated | Non-Small Cell Lung Cancer | >bevacizumab >sunitinib >carboplatin >paclitaxel | Phase_II | A Study of Sunitinib in C... | NCT00434226 |
| Complete | Metastatic Breast Cancer | >Paclitaxel >Gemcitabine >Avastin | Phase_II | A Study of Biweekly Gemci... | NCT00618826 |
| Completed | Neoplasms | >rhuMAb 2C4 | Phase_I | Safety Study of rhuMAb 2C... | NCT00027027 |
| Completed | Neovascular Age-Related Macular Degeneration | >Lucentis (Ranibizumab) | Phase_II | Prospective OCT Study Wit... | NCT00344227 |
| Terminated | Non-Hodgkin's Lymphoma | >PRO131921 | Phase_I Phase_II | A Trial of the Safety of ... | NCT00452127 |
| Terminated | Breast Cancer | >Bevacizumab (Avastin) >Bevacizumab (Avastin) >Bevacizumab (avastin) >Bevacizumab (avastin) >Bevacizumab (avastin) >Bevacizumab (avastin) | Phase_II | A Phase II Safety and Tol... | NCT00476827 |
| Completed | Non-small Cell Lung Cancer Brain Neoplasms | >bevacizumab >erlotinib HCl >chemotherapy | Phase_II | A Study of Bevacizumab in... | NCT00312728 |
| Completed | Healthy Volunteers | >GDC-0941 >rabeprazole | Phase_I | A Study to Determine the ... | NCT00999128 |
| Completed | Multiple Sclerosis | >placebo >rituximab | Phase_II Phase_III | A Study to Evaluate the S... | NCT00087529 |
| Completed | Cancer | >Pemetrexed >Bevacizumab | Phase_II | Study of Pemetrexed and B... | NCT00222729 |
| Completed | Carcinoma, Small Cell Lung Lung Cancer | >irinotecan >carboplatin >bevacizumab >Radiation Therapy | Phase_II | Irinotecan, Carboplatin, ... | NCT00308529 |
| Terminated | Liver Cancer Hepatocellular Carcinoma Cholangiocarcinoma | >Bevacizumab >Proton Radiation Therapy | Phase_I | Proton Therapy and Bevaci... | NCT00426829 |
| Completed | Non-small Cell Lung Cancer | >enzastaurin >pemetrexed >carboplatin >bevacizumab >Placebo | Phase_II | Study of Pemetrexed + Car... | NCT00533429 |
| Completed | Rectal Cancer | >Avastin (Bevacizumab, RHUMAB VEGF) >Capecitabine >Radiation Therapy | Phase_II | Neoadjuvant Chemoradiatio... | NCT00113230 |
| Completed | HIV Infections | >rgp120/HIV-1MN >rgp120/HIV-1 SF-2 | Phase_II | A Phase II Clinical Trial... | NCT00001031 |
| Completed | Carcinoma, Small Cell Lung | >irinotecan >carboplatin >bevacizumab | Phase_II | Irinotecan, Carboplatin, ... | NCT00294931 |
| Completed | Biliary Tract Adenocarcinoma Gallbladder Adenocarcinoma | >Bevacizumab >Gemcitabine >Oxaliplatin | Phase_II | Gemcitabine, Oxaliplatin ... | NCT00361231 |
| Completed | Renal Insufficiency | >placebo >tenecteplase | Phase_III | A Study of Tenecteplase f... | NCT00396032 |
| Terminated | Chronic Lymphocytic Leukemia | >PRO131921 | Phase_I Phase_II | A Trial of the Safety of ... | NCT00496132 |
| Completed | Asthma | >Xolair >Xolair >Placebo | Phase_II | A Study of Efficacy of Ne... | NCT00624832 |
| Completed | Macular Degeneration | >rhuFab V2 (ranibizumab) | Phase_III | Extension Study of rhuFab... | NCT00095433 |
| Completed | Urticaria | >Xolair® (Omalizumab) | Phase_II | Effect of Anti-IgE in Chr... | NCT00130234 |
| Completed | Hidradenitis Suppurativa | >efalizumab | Phase_I | Efficacy and Safety of Ef... | NCT00134134 |
| Completed | Allergic Asthma | >omalizumab >omalizumab >placebo | Phase_II | A Study of Omalizumab in ... | NCT00434434 |
| Completed | Nonarteritic Anterior Ischemic Optic Neuropathy | >ranibizumab | Phase_I | Ranibizumab Therapy for N... | NCT00561834 |
| Completed | Lung Cancer | >Tarceva (erlotinib HCl) | Phase_III | A Study With Tarceva and ... | NCT00047736 |
| Completed | Macular Degeneration | >rhuFab V2 (ranibizumab) | Phase_III | A Study to Evaluate rhuFa... | NCT00056836 |
| Completed | Non-small Cell Lung Cancer | >bevacizumab >carboplatin >paclitaxel | Phase_II | A Study of Bevacizumab Pl... | NCT00318136 |
| Terminated | Renal Cell Carcinoma | >bevacizumab >sunitinib >placebo | Phase_II | A Study Evaluating the Ef... | NCT00491738 |
| Completed | Prostate Cancer | >rhuMAb 2C4 (pertuzumab) | Phase_II | Safety and Efficacy Study... | NCT00058539 |
| Completed | Breast Cancer | >rhuMAb VEGF (Bevacizumab) | Phase_III | A Study of rhuMAb VEGF (B... | NCT00109239 |
| Terminated | Non-Small Cell Lung Cancer | >Bevacizumab >Erlotinib >Pemetrexed | Phase_I Phase_II | Phase I/II Trial of Bevac... | NCT00351039 |
| Completed | Breast Cancer | >enzastaurin >bevacizumab >paclitaxel >placebo | Phase_II | Trial of Paclitaxel, Beva... | NCT00536939 |
| Completed | Psoriasis Pregnancy | Phase_IV | An Observational Study of... | NCT00097240 | |
| Terminated | Head and Neck Cancer Carcinoma, Squamous Cell | >Erlotinib | Phase_II Phase_III | Erlotinib (Tarceva) Durin... | NCT00448240 |
| Completed | Solid Cancers | >pertuzumab | Phase_II | A Study to Evaluate Subje... | NCT00096941 |
| Completed | Breast Cancer Cancer of Breast Cancer of the Breast Breast Neoplasms | >gemcitabine >paclitaxel >bevacizumab | Phase_II | A Trial of Taxol and Beva... | NCT00320541 |
| Complete | Chronic Lymphocytic Leukemia | >lenalidomide, fludarabine and rituximab | Phase_I Phase_II | Fludarabine, Rituximab, a... | NCT00536341 |
| Terminated | Metastatic Breast Cancer | >Sorafenib >Bevacizumab >Imaging | Phase_II | A Phase II Study of Bevac... | NCT00632541 |
| Completed | HIV Infections Pregnancy | >CD4-IgG | Phase_I | A Phase I Study of the Sa... | NCT00000642 |
| Completed | Cystic Fibrosis | >Nutropin AQ [somatropin (DNA origin) injection] | Phase_II | A Study to Evaluate Nutro... | NCT00079742 |
| Completed | Psoriasis | >efalizumab | Phase_III | A Study to Evaluate Efali... | NCT00338143 |
| Completed | Plaque Psoriasis | >Efalizumab >Narrow Band Phototherapy | Phase_IV | A Safety and Efficacy Stu... | NCT00302445 |
| Completed | Acute Myocardial Infarction | An Observational Study of... | NCT00669045 | ||
| Completed | Foot Ulcer | >rhuMAb VEGF (telbermin) | Phase_I | A Study Evaluating Topica... | NCT00069446 |
| Terminated | Colorectal Cancer | >Avastin | Phase_IV | A Study to Compare Two Av... | NCT00114946 |
| Completed | Chronic Rejection Kidney Insufficiency | >Rituximab | Phase_I Phase_II | Rituximab Treatment to Bl... | NCT00261547 |
| Basal Cell Carcinoma Metastatic Colorectal Cancer Ovarian Cancer | >bevacizumab >FOLFIRI >FOLFOX >GDC-0449 | Phase_II | A Study of GDC-0449 (Hedg... | NCT00959647 | |
| Completed | Peanut Hypersensitivity | >omalizumab | Phase_II | A Study of Xolair in Pean... | NCT00382148 |
| Completed | Asthma | >Omalizumab | Phase_III | Safety and Tolerability o... | NCT00482248 |
| Completed | Eales' Disease | >Ranibizumab | Phase_II Phase_III | Lucentis (Ranibizumab) fo... | NCT00384449 |
| Completed | Immune Thrombocytopenic Purpura ( ITP ) HIV Infections | >CD4-IgG | Phase_I | A Phase I Study of Recomb... | NCT00002250 |
| Withdrawn | B-cell Chronic Lymphocytic Leukemia | >ABT-263 | Phase_II | Study Assessing the Safet... | NCT00918450 |
| Malignant Glioma | >Radiosurgery >Bevacizumab | Radiosurgery and Avastin ... | NCT01017250 | ||
| Completed | Colorectal Cancer Neoplasm Metastasis | >Tarceva (OSI-774) >Capecitabine >Oxaliplatin | Phase_II | Tarceva, Capecitabine and... | NCT00123851 |
| Completed | Choroidal Neovascularization | >ranibizumab | Phase_I | Safety Study of Ranibizum... | NCT00395551 |
| Completed | Kidney Failure, Chronic Diabetic Nephropathies Glomerulonephritis, IGA Hypertension, Renal | >Rituximab >Mycophenolate mofetil (MMF) | Phase_II | Effects of Rituximab and ... | NCT00446251 |
| Completed | Breast Cancer | >AC [Adriamycin (A) (also known as doxorubicin) and Cyclophosphamide (C)] Followed By Paclitaxel (P) | Phase_II | Phase II Study of Dose-De... | NCT00591851 |
| Completed | Ovarian Cancer | >Pertuzumab (rhuMAb 2C4) | Phase_II | A Study to Evaluate the E... | NCT00058552 |
| Completed | Psoriasis | >Raptiva (efalizumab) | Phase_III | A Study to Evaluate Rapti... | NCT00109252 |
| Terminated | Colorectal Neoplasms | >Bevacizumab >Oxaliplatin >Capecitabine >Irinotecan | Phase_II | Study of Bevacizumab Comb... | NCT00314353 |
| Completed | Renal Insufficiency | >tenecteplase | Phase_III | A Study of Tenecteplase f... | NCT00396253 |
| Completed | Non-Small Cell Lung Cancer | >rhuMAb 2C4 (pertuzumab) | Phase_II | Safety and Effect of Pert... | NCT00063154 |
| Completed | Hypopituitarism | >Arimidex (Anastrozole) | Phase_II Phase_III | Arimidex Multicenter Tria... | NCT00133354 |
| Completed | Kidney Cancer | >OSI-774 >Bevacizumab | Phase_II | OSI-774 and Bevacizumab i... | NCT00193154 |
| Completed | Psoriasis | >Methotrexate >Raptiva | Phase_I Phase_II | Evaluate Whether Combinat... | NCT00368654 |
| Completed | HIV Infections | >rgp120/HIV-1MN >Zidovudine | Phase_I | A Phase I/II Trial of Vac... | NCT00000755 |
| Completed | Kidney Transplant | >IVIG and Rituximab | Phase_I Phase_II | Rituximab and Intravenous... | NCT00642655 |
| Withdrawn | Choroidal Neovascularization | >Imatinib Mesylate /Ranibizumab | Phase_I | Imatinib Mesylate Combine... | NCT00403156 |
| Terminated | Metastatic Breast Cancer | >bevacizumab >sunitinib >paclitaxel | Phase_II | A Study of Sunitinib in C... | NCT00434356 |
| Completed | Cancer | >Avastin (bevacizumab) | Phase_II | An Extension Study to Eva... | NCT00109057 |
| Withdrawn | Lupus Nephritis | >Rituximab | Phase_III | A Study to Evaluate the S... | NCT00404157 |
| Completed | Choroidal Neovascularization Age-Related Macular Degeneration | >rhuFab V2 (ranibizumab) | Phase_III | A Study to Evaluate Ranib... | NCT00251459 |
| Withdrawn | Diabetic Macular Edema | >Efalizumab >Ranibizumab | Phase_I | Combined aPproach to Trea... | NCT00676559 |
| Completed | Neoplasm, Unknown Primary | >paclitaxel >carboplatin >bevacizumab >erlotinib | Phase_II | Paclitaxel/Carboplatin Pl... | NCT00360360 |
| Completed | HIV Infections | >Interferon gamma-1b | Phase_I | Phase I/II Study of Recom... | NCT00000761 |
| Completed | Lymphoma | >Avastin >Rituximab | Phase_II | Avastin Plus Rituximab fo... | NCT00081861 |
| Terminated | Chronic Kidney Disease | >Recombinant Human Growth Hormone | Phase_IV | Effect of Growth Hormone ... | NCT00194961 |
| Completed | Growth Hormone Deficiency | Cardiovascular Risk in Gr... | NCT00711061 | ||
| Completed | HIV Infections | >rgp120/HIV-1MN >rgp120/HIV-1 SF-2 >gp160 Vaccine (MicroGeneSys) | Phase_I | A Placebo-Controlled, Pha... | NCT00000762 |
| Completed | Colorectal Cancer | >Erlotinib (aka Tarceva or OSI-774) >Bevacizumab (aka Avastin or Rhu MAb VEGF) | Phase_I | Safety, Efficacy, and Pha... | NCT00047762 |
| Completed | Asthma | >rhDNAse (pulmozyme) | Phase_II | Study of Pulmozyme to Tre... | NCT00169962 |
| Urticaria | >Rituximab | Phase_I Phase_II | Safety Study of Rituximab... | NCT00216762 | |
| Completed | HIV Infections | >CD4-IgG | Phase_I | A Phase I Study of the Sa... | NCT00000663 |
| Completed | Lymphoma | >rituximab >vinorelbine ditartrate | Phase_II | Chemotherapy and Monoclon... | NCT00003963 |
| Completed | Lung Cancer Non-Small-Cell Lung Carcinoma | >Tarceva (erlotinib HCl) | Phase_III | A Study to Evaluate Tarce... | NCT00091663 |
| Completed | Breast Cancer | >Trastuzumab >Gemcitabine | Phase_II | Weekly Gemcitabine and Tr... | NCT00193063 |
| Completed | Glioblastoma | >bevacizumab >irinotecan | Phase_II | A Study to Evaluate Bevac... | NCT00345163 |
| Terminated | Diabetes Mellitus, Type 1 | >efalizumab >placebo | Phase_II | Beta Cell Rescue in New O... | NCT00737763 |
| Withdrawn | Idiopathic Thrombocytopenic Purpura (ITP) | >Rituximab | Phase_II | A Trial to Treat Patients... | NCT00161564 |
| Diabetic Macular Edema Visual Impairment | >ranibizumab | Phase_III | An Open-label Extension S... | NCT00906464 | |
| Completed | Breast Cancer | >Erlotinib HCl (OSI-774) | Phase_II | A Study to Evaluate Erlot... | NCT00109265 |
| Completed | Allergic Asthma | >HAE1 (PRO98498) | Phase_II | A Study to Evaluate the S... | NCT00406965 |
| Terminated | Pancreatic Cancer | >Avastin, Fluorouracil, Doxorubicin, Streptozocin | Phase_II | Avastin, Fluorouracil, Do... | NCT00609765 |
| Completed | Rheumatoid Arthritis | >rituximab | Phase_II | Assessment of Rituximab's... | NCT00147966 |
| Withdrawn | Age Related Macular Degeneration AMD CNV | >Efalizumab, Ranibizumab | Phase_I | Study of Efalizumab Combi... | NCT00726466 |
| Completed | Breast Cancer Colorectal Cancer Metastases | >Avastin (bevacizumab) | Phase_III | A Study to Evaluate Avast... | NCT00096967 |
| Completed | Hepatocellular Carcinoma | >Gemcitabine >Oxaliplatin >Bevacizumab | Phase_II | Gemcitabine, Oxaliplatin ... | NCT00142467 |
| Completed | Foot Ulcer, Diabetic | >placebo >telbermin | Phase_II | A Study to Assess the Eff... | NCT00351767 |
| Completed | Waldenstrom's Macroglobulinemia | >CC-5103 >Rituximab | Phase_II | CC-5013 and Rituximab in ... | NCT00142168 |
| Completed | Choroidal Neovascularization | >Ranibizumab >Ranibizumab | Phase_I Phase_II | Ranibizumab in Hemorrhagi... | NCT00363168 |
| Completed | Metastatic Solid Tumor | >Topotecan >Erlotinib | Phase_I | Phase I, Dosage-finding a... | NCT00611468 |
| Withdrawn | Kidney Transplantation | >basiliximab >efalizumab >mycophenolate mofetil >corticosteroids >cyclosporine | Phase_II Phase_III | A Study to Evaluate Efali... | NCT00729768 |
| Completed | Metastatic Pancreatic Cancer | >bevacizumab >gemcitabine >oxaliplatin | Phase_II | Combination Chemotherapy ... | NCT00222469 |
| Withdrawn | Adrenocortical Carcinoma | >Bevacizumab | Phase_II | Treatment Study Using Bev... | NCT00469469 |
| Completed | Rheumatoid Arthritis | >ocrelizumab | Phase_I Phase_II | A Study to Evaluate the S... | NCT00077870 |
| Completed | Colorectal Cancer | >Avastin (bevacizumab) | Phase_III | A Study to Evaluate Avast... | NCT00109070 |
| Completed | Cancer | >Topotecan >Docetaxel | Phase_I | Topotecan in Combination ... | NCT00193570 |
| Terminated | Hemophilia A | >Rituxan >prednisone | Phase_II Phase_III | Trial of Rituximab Versus... | NCT00306670 |
| Terminated | Ovarian Cancer Peritoneal Cancer Fallopian Tube Cancer Stage 3 Cancer Stage 4 Cancer | >Bevacizumab >Carboplatin >Paclitaxel | Phase_II | Bevacizumab Study With Ca... | NCT00408070 |
| Complete | Port Wine Stain Birthmarks | >combined laser and ranibizumab treatment | Phase_I | Combined Pulsed Dye Laser... | NCT00667472 |
| Completed | Crohn's Disease | >Somatropin, E-coli Derived | Phase_II | Trial of Growth Hormone T... | NCT00109473 |
| Completed | Psoriasis | >efalizumab | Phase_IV | A Study to Evaluate Rapti... | NCT00336973 |
| Terminated | Carcinoma, Renal Cell | >Bevacizumab >Interleukin-2 | Phase_II | Safety Study of Specific ... | NCT00440973 |
| Complete | Thrombotic Thrombocytopenic Purpura | >Rituximab >Plasma exchange >Corticosteroids | Phase_III | Evaluating the Effectiven... | NCT00799773 |
| Completed | Asthma | >omalizumab >placebo >corticosteroids >long-acting beta-agonists | Phase_III | A Study of Xolair in Subj... | NCT00314574 |
| Completed | HIV Infections | >CD4-IgG | Phase_I | A Phase I Study of the Sa... | NCT00000675 |
| Withdrawn | Myelodysplastic Syndrome | >Erlotinib | Phase_II | The Role of Erlotinib an ... | NCT00570375 |
| Completed | HIV Infections | >CD4-IgG >Zidovudine | Phase_I | A Phase I Study of the Sa... | NCT00000976 |
| Completed | Breast Cancer | >Gemcitabine >Carboplatin >Trastuzumab | Phase_II | Combination Gemcitabine, ... | NCT00193076 |
| Completed | Dysfunctional Central Venous Access Catheters | >placebo >tenecteplase | Phase_III | A Study of Tenecteplase f... | NCT00395876 |
| Terminated | Plaque Psoriasis | >Calcipotriene/betamethasone | Phase_IV | Effect of Topical Calcipo... | NCT00608777 |
| Completed | Metastatic Breast Cancer | >ABT-869 >paclitaxel >Placebo for ABT-869 | Phase_II | Phase 2 Study of ABT-869 ... | NCT00645177 |
| Completed | Solid Cancers | >bevacizumab >MetMAb >MetMAb | Phase_I | A Study of the Safety and... | NCT01068977 |
| Terminated | Renal Cell Cancer | >rhuMAb VEGF (Bevacizumab) | Phase_III | Efficacy and Safety Study... | NCT00061178 |
| Terminated | Asthma Allergy | >omalizumab | Effect of Ozone on Airway... | NCT00287378 | |
| Completed | Non-Hodgkin Lymphoma | >SGN-40 (anti-huCD40 mAb) | Phase_I | A Safety Study of SGN-40 ... | NCT00103779 |
| Completed | Allergic Asthma | >RhuMab-E25 | Phase_III | Role of RhuMab-E25 in Red... | NCT00829179 |
| Completed | Psoriasis | >Raptiva (efalizumab) | Phase_IV | A Study to Evaluate Rapti... | NCT00096980 |
| Completed | Dysfunctional Central Venous Access Devices (CVADS) | >Cathflo Activase (Alteplase) | Phase_IV | Cathflo Activase Pediatri... | NCT00307580 |
| Withdrawn | Alopecia Totalis | >efalizumab | Phase_II | Efalizumab in the Treatme... | NCT00746980 |
| Fallopian Tube Cancer Ovarian Cancer Peritoneal Cancer | >D4064A | Phase_I | A Study of D4064A Adminis... | NCT00753480 | |
| Terminated | Dialysis Catheter Fibrin Sheath Clotted Dialysis Catheter Catheter Malfunction | >TPA Infusion | Rt-PA Infusion Versus Cat... | NCT00194181 | |
| Completed | Non-Small Cell Lung Cancer | >oxaliplatin, gemcitabine, bevacizumab | Phase_II | Study of Oxaliplatin and ... | NCT00217282 |
| Complete | Chronic Renal Insufficiency | >Recombinant Human Growth Hormone | Phase_IV | Effect of Cytokines on Gr... | NCT00194883 |
| Completed | Glioblastoma | >Erlotinib HCl (OSI-774) | Phase_II | A Study of the Safety and... | NCT00337883 |
| Completed | Lung Cancer | >Bevacizumab >Pemetrexed >Radiation therapy | Phase_II | Chemotherapy, Radiotherap... | NCT00402883 |
| Completed | HIV Infections | >CD4 Antigens | Phase_I | A Phase I Study of the Sa... | NCT00000984 |
| Completed | Asthma | >Xolair (omalizumab) | Phase_III | An Extension Study of Xol... | NCT00109187 |
| Completed | Multiple Sclerosis | >rituximab | Phase_II | A Study to Evaluate Ritux... | NCT00097188 |
| Completed | Chronic Idiopathic Urticaria | >omalizumab >placebo | Phase_II | A Study of Xolair (Omaliz... | NCT00866788 |
| Completed | Lymphoma | >rituximab | Phase_II | Rituximab in Treating Pat... | NCT00004889 |
| Completed | Thymic Cancer Thymoma | >bevacizumab >Erlotinib | Phase_II | A Study to Test the Safet... | NCT00369889 |
| Completed | Breast Cancer | >Letrozole in combination with Bevacizumab | Phase_II | Open Label Trial for Post... | NCT00161291 |
| Terminated | End Stage Renal Disease | >rituximab | Rituximab Desensitization... | NCT00167791 | |
| Completed | HIV Infections | >rgp120/HIV-1IIIB | Phase_I | A Phase I Study of the Sa... | NCT00001992 |
| Terminated | Myocardial Infarction | >Tenecteplase >PCI | Phase_IV | A Trial Evaluating the Ef... | NCT00168792 |
| Completed | Ovarian Cancer Peritoneal Cancer Fallopian Tube Cancer | >rhuMAb 2C4 (pertuzumab) | Phase_II | A Study to Evaluate rhuMa... | NCT00096993 |
| Completed | Lung Cancer | >Bevacizumab >Bortezomib | Phase_I Phase_II | Phase I-II for Patients W... | NCT00411593 |
| Completed | Macular Degeneration | >rhuFab V2 (ranibizumab) | Phase_III | A Study to Compare rhuFab... | NCT00061594 |
| Completed | Bladder Cancer | >Cisplatin >Gemcitabine >Bevacizumab | Phase_II | Cisplatin, Gemcitabine an... | NCT00234494 |
| Non-Small Cell Lung Cancer | >Erlotinib (drug) | Phase_II | Phs. II Study of OSI-774 ... | NCT00200395 | |
| Completed | Anorexia Nervosa Osteopenia Osteoporosis Eating Disorders | >Recombinant Human Growth Hormone >Placebo for Recombinant Human Growth Hormone | Phase_II | Effect of Growth Hormone ... | NCT00283595 |
| Completed | Telangiectasia | >Ranibizumab >Ranibizumab | Phase_I Phase_II | Ranibizumab in Idiopathic... | NCT00378196 |
| Completed | Asthma | >Xolair (omalizumab) | Phase_III | A Study to Evaluate the S... | NCT00401596 |
| Completed | Kidney Transplantation | >Rituximab for transplant rejection | Phase_II Phase_III | Rituximab for Pediatric R... | NCT00697996 |
| Withdrawn | Esophageal Carcinoma | >Bevacizumab, cetuximab | Phase_II | Study of Cetuximab and Be... | NCT00636298 |
| Allergic Asthma | >omalizumab >placebo | Phase_IV | A Study Evaluating the Pe... | NCT01125748 | |
| Basal Cell Carcinoma | >GDC-0449 | Phase_II | A Study of GDC-0449 in Pa... | NCT01160250 | |
| Metastatic Breast Cancer | >trastuzumab-MCC-DM1 | Phase_II | A Study of Trastuzumab-MC... | NCT01120561 | |
| Terminated | Non-Hodgkin's Lymphoma | >Rituximab | Phase_III | Rituximab Maintenance Aft... | NCT01103388 |
| Completed | Healthy Volunteers | >GDC-0973/XL518 | Phase_I | An Absolute Bioavailabili... | NCT01249118 |
| Completed | Healthy Volunteer | >GDC-0973/XL518 >GDC-0973/XL518 >rabeprazole >rabeprazole | Phase_I | A Study to Evaluate the E... | NCT01277718 |
| Completed | Healthy Volunteers | >GDC-0973/XL518 >GDC-0973/XL518 >GDC-0973/XL518 | Phase_I | A Study of Relative Bioav... | NCT01249131 |
| Completed | Subfoveal(CNV) Secondary to(AMD) | >Ranibizumaab | Evaluation of the Effect ... | NCT01256632 | |
| Complete | Asthma | >Real-time asthma care outreach | Phase_IV | Reduce IDentified UNcontr... | NCT01449409 |
| Age-related Macular Degeneration | Genetic Assessment of Ear... | NCT01464710 | |||
| Completed | Moderate to Severe Allergic Asthma | Observational and Epidemi... | NCT01362621 | ||
| Completed | Prematurity of Fetus | >Oseltamivir | Pharmacokinetics of Oselt... | NCT01388439 | |
| Completed | Sepsis Acute Lung Injury Acute Respiratory Distress Syndrome | >TNX-832 >Placebo | Phase_I | Effects of TNX-832 (Sunol... | NCT01438853 |
| Completed | Macular Edema Retinal Vein Occlusion | >Ranibizumab 0.5 mg | An Extension Study to Eva... | NCT01442064 | |
| Completed | Healthy Volunteer | >GDC-0941 | Phase_I | Study to Investigate the ... | NCT01474668 |